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Abstract 
The transfusion of blood products can lead to life-threatening complications after surgery. In 
addition, blood products are a scarce and expensive resource. Even though anemia in coronary 
artery bypass surgery patients is currently undertreated, research has shown that the intravenous 
infusion of iron products, as well as a single dose of erythropoietin-alpha prior to surgery, 
decreases the amount of blood products used in the perioperative setting. The goal of this pilot 
project was to increase the number of patients screened for anemia, and if necessary, treated 
prior to coronary artery bypass graft surgery.  
Methods: This was a practice improvement, pilot project within a preoperative assessment 
center in a large Midwestern health system. The population included outpatient coronary artery 
bypass graft surgical patients. The presence of anemia was determined prior to the required 
cardiac catheterization before coronary artery bypass graft surgery. Through a new process, 
patients diagnosed with anemia were referred to the preoperative assessment center for 
optimization and treatment management. The results of this quality improvement project showed 
an increase in the number of patients who received treatment for their anemia prior to surgery.  
Conclusions: The literature suggests that a decreased use of blood products will result in fewer 
complications following cardiac surgery. While this pilot project did not show a statistical 
difference in the amount of blood products used, there was a clinically meaningful improvement 
as the new process for anemia management increased the number of patients treated for anemia 
prior to surgery. 
Implications: This new referral process was successful in treating preoperative anemia. 
Continued improvement in the treatment of anemia is needed to decrease the number of post-
surgical complications that may arise from anemia in this population of coronary artery bypass 
graft patients. 
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Preoperative Anemia Management in Adult Outpatient Coronary Artery Bypass Graft Surgical 
Patients to Improve Treatment of Preoperative Anemia 
Anemia is a condition where the amount of hemoglobin circulating in the blood is 
inadequate to meet the body’s physiologic needs. According to the World Health Organization 
(WHO) (2008), anemia is defined as a hemoglobin concentration of less than 12 g/dL in non-
pregnant women and less than 13 g/dL in men. While there are many conditions that can lead to 
anemia, approximately 50% of occurrences are due to iron deficiency (WHO, 2008). Iron 
deficiency anemia is most often caused by malnutrition and is the most common form of anemia, 
followed closely by chronic disease anemia caused by inflammation or cancer (Peters, 
Ellermann, & Steinbicker, 2018). Anemia caused by inflammation may reduce iron availability, 
erythropoietin production in the kidney, and may result in a diminished bone marrow response 
to erythropoietin (Peters et al., 2018). Preoperative anemia is common among cardiac surgical 
patients with multiple comorbidities or advanced age. Moreover, major surgical procedures, such 
as cardiac surgery, may result in considerable blood loss either intra- or post-procedure, which 
can also result in anemia. 
The treatment for iron deficiency anemia includes oral or intravenous (IV) iron 
supplementation, erythropoietin-alpha (EPO), or allogeneic red blood cell transfusion (aRBCt). 
A number of patients who have anemia due to blood loss require aRBCt. The likelihood of 
needing a blood transfusion is increased if preoperative anemia exists (Weltert et al., 2015). It is 
important to diagnose and treat anemia, as it is associated with poor outcomes after cardiac and 
non-cardiac surgery and can lead to increased length of hospital stay, adverse effects and 
complications from surgery, and mortality (Clevenger et al., 2016; dos Santos et al., 2013; Hung, 
Besser, Sharples, Nair, & Klein, 2011).  
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Even though aRBCt can improve oxygen delivery quickly, it is not the treatment of 
choice because of the associated complications, such as atrial fibrillation, stroke, respiratory 
infections, sepsis, myocardial infarction, and death (dos Santos et al., 2013; dos Santos, et al., 
2014). For example, the use of aRBCt can impact increased postoperative mortality by 70% for 
patients who have cardiac surgery (dos Santos et al., 2014). Despite efforts to reduce aRBCt in 
cardiac surgery, it remains a common practice. Other therapies, such as the administration of iron 
therapy, whether oral or IV, in combination with EPO or as a single therapy, has been shown to 
increase hemoglobin concentration and reduce the use of aRBCt (Clevenger et al., 2016; 
Gurusamy, Nagendran, Broadhurst, Anker, & Richards, 2014; Lin, Lin, & Tran, 2013; Litton, 
Xiao, & Ho, 2013; Peters et al., 2018). Understanding the pathophysiology of functional iron 
deficiency is important when choosing to use EPO or iron supplementation to treat preoperative 
anemia as the origins of anemia change the course of treatment. A single dose administration of 
EPO prior to cardiac surgery has been shown to be effective in minimizing the need for aRBCt 
without increasing adverse events (Cladellas et al., 2012; Weltert et al., 2015; Yoo et al., 2011) 
In addition to the complications of aRBCt, cost is also a burden. The average cost of 
aRBCt, when including all of the process steps, staff, and overhead cost, is $761 ± $294 per 
transfusion (Shander et al., 2010). Blood products are also a scarce resource. In July 2018, the 
American Red Cross reported a critical blood shortage that resulted in an emergency call for 
eligible donors (The American National Red Cross, 2018). Blood donations fell short of 
expectations in May and June 2018, resulting in 61,000 fewer donations than needed (The 
American National Red Cross, 2018). Due to the scarcity of blood and the associated 
complications, safe and effective strategies to reduce aRBCt are needed.   
The purpose of this project was to implement an evidence-based practice improvement 
initiative to improve the treatment of iron deficiency anemia prior to coronary artery bypass 
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(CABG) surgery in a large Midwestern health system (MHS). Evidence regarding the assessment 
of the current state of the Midwestern health system is included.  
Current Practice 
The process used to assess preoperative patients for anemia in MHS was evaluated. 
Current practice included patient identification in the cardiac catheterization lab (cath lab) as a 
possible candidate for CABG by the interventional cardiologist. From there, a registered nurse 
within interventional cardiology services ordered the appropriate tests and referred the patient to 
cardiothoracic surgery (CTS) for evaluation. After the cardiothoracic surgeon met with the 
patient, the surgeon determined if surgery was the appropriate intervention. If surgery was 
indicated, it was scheduled within two to three weeks of the initial surgical consultation. The 
patient was then referred to the primary care provider for preoperative assessment and 
optimization of chronic diseases prior to surgery. The provider optimizes existing medical issues 
and recommends management of them in the perioperative period in coordination with other 
providers involved in care.  
Society of Thoracic Surgeon’s Data 
The Society of Thoracic Surgeon’s (STS) National Database was established as an 
initiative to improve patient safety and quality of care among cardiothoracic surgeons. The STS 
Adult Cardiac Surgery Database is the world’s leading clinical outcomes registry for adult 
cardiac surgery (D’Agostino et al., 2018). The database includes both national and specific 
organization data (D’Agostino et al., 2018). As of June 2018, 1081 organizations in the United 
States have participated in this database (D’Agostino et al., 2018). MHS uses the database as a 
benchmark to guide practice within CTS. 
According to the STS 2018 data, 38% of all patients (inpatient and outpatient) in MHS 
who undergo cardiac surgery are anemic at the time of surgery. This is somewhat higher than a 
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large multicenter cohort study where the overall prevalence of preoperative anemia was 26% 
(Karkouti, Wijeysundera, & Beattie, 2008). Further, approximately 30% of patients in MHS 
from the outpatient setting who undergo cardiac surgery were anemic. Of these 30% who were 
anemic, only 17% of outpatient CABG patients were identified as anemic prior to surgery and 
treated with oral iron supplements, vitamin B-12, and/or EPO injections. Improvement in 
identification and treatment of anemia preoperatively was needed. 
Assessment of the Health System 
Model Overview 
The Burke and Litwin Model of Organizational Performance and Change (1992) 
framework and a SWOT analysis were used to guide the organizational assessment for this 
project (see Appendix A). The Burke and Litwin model (1992) outlines 12 elements that may 
affect the overall success of an organizational change effort. The model includes casual 
elements, meaning that that these elements interact with and affect each other. The structure of 
the model includes two dynamics that provide guidance for describing the macro and micro 
levels of organization: culture and climate, respectively. Culture is defined as the organization 
beliefs and values. Climate is defined in terms of how individuals perceive their local work unit 
is managed and how they and their coworkers work together. Climate is influenced by the overall 
culture of the organization.  
The model distinguishes among the 12 elements by terming them transactional or 
transformational variables. Transactional variables are affected by human behavior on the micro 
level: everyday interactions and exchanges on the work unit such as the structure, management 
practices, systems, work unit climate, task and individual skills, motivation, and individual needs 
and values. Transformational variables are concerned with macro level organizational processes 
and culture changes in behavior. Transformational variables interact with the environment, 
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whether external or internal. These are the most influential in organizational change and include 
external environment, mission and strategy, leadership, and organizational culture. Changes in 
transformational processes are required to enact lasting change in an organization. While 
transformational variables influence lasting change, transactional variables remain important and 
should be assessed as both sets of variables interact and affect individual and organizational 
performance.  
Organizational Assessment 
The managing physician in the preoperative assessment center (PAC), an interventional 
cardiology registered nurse, and a clinical practice specialist for cardiothoracic surgery were 
interviewed to obtain a deeper understanding of the transactional dynamics of the organization. 
The external environment was a strong motivator to change practice and reduce blood usage due 
to the scarcity of blood products, the potential for serious adverse effects, and the high cost of 
blood products.  
The mission and strategy, leadership, structure, work unit climate, individual abilities of 
staff, and culture all served as facilitators for this practice change initiative. The mission of MHS 
promotes quality improvement initiatives to “improve the health of communities…” that they 
serve. The climate and leadership qualities in both the CTS and PAC offices are strong, positive, 
and encourage change projects that will positively affect the patients. Each office is committed to 
quality improvement and strives to exceed the national benchmarks for adult surgical outcomes. 
An identified potential barrier was that this health system does not have an effective process in 
place for ordering and managing IV infusions. This was addressed prior to implementing the 
practice change.  
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Ethics and Protection of Human Subjects 
The Institutional Review Boards (see Appendix B and C) of the university and site 
determined the project was quality improvement.  
Stakeholders 
A project cannot function properly without key stakeholders invested in the project 
(Moran, Burson, & Conrad, 2017). Key stakeholders in this anemia management project 
included healthcare providers (physicians, nurse practitioners, and physician assistants), 
registered nurses, pharmacists, infusion clinic staff, quality improvement specialists, laboratory 
technicians, outpatient cardiology office staff, and patients. Healthcare providers were included 
as stakeholders as prescribers of blood, iron infusion products, and preoperative testing. 
Pharmacists were included because they mix the iron infusion products and were instrumental in 
creating the algorithm for proper anemia management. Other stakeholders that were identified 
included infusion clinic personnel because they administer the infusion, laboratory technicians 
because of the need to draw appropriate labs, and finally the patients who receive the blood 
products or iron infusions. Outpatient cardiology office staff were instrumental in assisting the 
DNP student with the project.  
SWOT: Strengths, Weakness, Opportunities, and Threats 
A SWOT analysis is a tool used to perform an assessment of an organization’s strengths, 
weaknesses, opportunities, and threats (Moran, Burson, & Conrad, 2017). The evaluation of the 
internal strengths and weaknesses, along with the evaluation of the external opportunities and 
threats, provides a general overview of the current state of the organization. Strengths refer to the 
internal traits that are helpful to a program, such as efficient processes, experienced staff, or an 
aesthetically appealing environment (Moran, Burson, & Conrad, 2017). Weaknesses denote the 
internal traits that are harmful to a program, such as underlying tension in the office or 
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knowledge gaps. Opportunities are the external traits or changes that could help the program, 
while threats refer to the external traits or changes that may be harmful. The strengths, 
weaknesses, opportunities, and threats of the preoperative assessment center in a large MHS 
were analyzed per discussions with key stakeholders; specifically, with the nursing practice 
manager (see Appendix D).  
The strengths of the PAC were identified and included motivated leaders and consistent, 
expert providers in the realm of preoperative assessment, and a close relationship to the 
connecting hospital. The PAC offers a comprehensive preoperative optimization visit with 
enhanced quality of care by incorporating evidence-based practice measures. The PAC was 
affiliated with a Magnet® designated health system, which is a distinction that honors nursing 
excellence and high-quality patient care. The PAC also has opportunities. The PAC has 
bandwidth for providers to see more patients to manage care prior to surgery. The PAC enjoys a 
close relationship with its existing providers and anesthesiologists, which has resulted in 
effective communication.  
Weaknesses of the PAC included gaps in needed professions, such as a pharmacist to 
oversee medication changes and dosing, dieticians to aid in lifestyle education and modification, 
and a medical assistant to collect blood samples. Historically, MHS had not had a process in 
place to order and manage IV infusions. This frustrated providers, which may be why IV 
infusions were not done as frequently as needed.  
Threats were also identified. CTS and the PAC did not have a working relationship, 
which may have caused hesitancy to collaborate due to a lack of trust. As an organization, MHS 
had not thus far encouraged preoperative anemia management, which may have caused some 
push-back from stakeholders during process change. It is important to be aware of and address 
these weaknesses and threats to lessen their effect on the practice change. 
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Clinical Practice Question 
The clinical practice question was: If patients are referred to a preoperative assessment 
center prior to CABG surgery for preoperative anemia work-up, will the number of patients 
undergoing CABG surgery with untreated anemia decrease? 
Review of the Literature 
To determine best practice for preoperative anemia management, a literature review was 
conducted. The primary objective of the review was to identify detection and treatment of 
preoperative anemia in CABG patients. Therefore, safe, effective, and evidence-based methods 
to treat preoperative anemia were examined. The central theme of the review was iron infusion 
and EPO administration prior to cardiothoracic surgery, as they are safe and cost-effective 
alternatives to blood product use. 
Methods 
 PRISMA. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guideline served as the framework for the review (Moher, Liberati, Tetzlaff, Altman, 
& PRISMA Group, 2009). A comprehensive electronic search was conducted in the Google 
Scholar, PubMed, and Cochrane Library databases. The search was limited to reviews in the 
English language during the period of 2013 to 2018. Reference lists from the included studies 
were reviewed to identify potential additional sources. Keywords included: anemia, preoperative 
anemia, cardiac surgery, anemia management, cardiac, adult, iron infusion, and erythropoietin. 
Results were filtered to only show systematic reviews, meta-analyses, and randomized control 
trials.  
Aim of the Review. This review answered four questions: 
• Does any formulation of iron supplementation therapy increase hemoglobin 
concentration in anemic patients? 
PREOPERATIVE ANEMIA MANAGEMENT  
 
 
14 
• What formulation of iron supplementation is safe and effective in improving hemoglobin 
levels in anemic patients?  
• What formulation of iron supplementations reduces the risk of aRBCt in anemic patients? 
• Is EPO therapy safe and efficacious in reducing the use of aRBCt in cardiac surgery? 
Inclusion and Exclusion Criteria  
 Article Types. Included in the literature review were randomized control trials (RCT), 
systematic reviews, and meta-analyses. Excluded were studies less than an RCT. 
Population. Included were samples that featured non-pregnant, anemic adults without 
chronic kidney disease. Pediatric populations, adults with chronic kidney disease, emergency 
surgeries, treatment refusal, and patients allergic to iron were excluded. 
 Intervention. Articles with multifactorial and single interventions were included in this 
review. Articles that only reported study results without stating the mechanisms of the 
intervention were excluded.  
 Comparison. Articles that included any type of iron preparation were included in this 
review. Articles that compared single or multifactorial interventions with a placebo were 
included in this review. Articles that used EPO as a single-dosed intervention or in conjunction 
with iron supplementation were included. Articles that did not use either iron supplementation or 
EPO therapy prior to surgery were excluded.  
 Outcome. Reviews that reported the outcome of an intervention on preoperative anemia 
measured in one of, or in a combination of the following were included: change in hemoglobin 
concentration pre- and post-intervention, morbidity and mortality, length of hospital stay, and 
blood transfusion requirement. Studies that did not include at least one of these measures were 
excluded.  
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Search Outcomes 
 The search yielded 324 studies (see Appendix E). Twenty-two were retrieved from the 
Cochrane Library, 241 from Google Scholar, and 61 from PubMed. Three articles were found 
through review of reference lists of included studies. Seven duplicates were found. After 
removing the duplicates, the titles and abstracts of 320 articles were screened. After reviewing 
the titles and abstracts, 290 articles were excluded for reasons pertaining to population, 
intervention, comparison, and outcome. Thirty full-text articles were assessed for eligibility 
using inclusion and exclusion criteria according to PRISMA criteria (Moher et al., 2009). 
Review of titles and abstracts resulted in removal of 22 articles that did not meet the inclusion 
criteria; the remaining eight articles were included in this review.  
Summary of Results 
Eight articles met the inclusion criteria and were included (see Appendix F). Included in 
this literature review were two Cochrane Reviews (Clevenger et al., 2016; Gurusamy et al., 
2014), two systematic reviews (Lin et al., 2013; Litton et al., 2013), three RCTs (Cladellas et al., 
2012; Weltert et al., 2015; Yoo et al., 2011), and one comprehensive review article (Peters et al., 
2018). 
Project Evidence 
The authors of these reviews found use of iron therapy and/or EPO to correct 
preoperative anemia is safe and efficacious. The authors of four of eight reviews supported the 
use of iron therapy, specifically IV iron to treat anemia (Clevenger et al., 2016; Gurusamy et al., 
2014; Litton et al., 2013; Peters et al., 2018). There was some evidence that oral iron is also 
efficacious in treating anemia, but less so than IV iron (Clevenger et al., 2016; Gurusamy et al., 
2014; Lin et al., 2013). The authors of all articles measured a change in blood transfusion 
requirements. The authors of three reviews described a decrease in the proportion of people who 
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required blood transfusion after supplementation with both oral and IV iron compared with 
inactive control (Clevenger et al., 2016; Gurusamy et al., 2014; Peters et al., 2018). Two of the 
eight RCTs supported use of a single dose of EPO prior to cardiac surgery to reduce aRBCt 
(Weltert et al., 2015; Yoo et al., 2011). Two of eight studies supported the use of EPO combined 
with IV iron to reduce aRBCt (Cladellas et al., 2012; Lin et al., 2013). 
The authors of three of the eight studies examined a decrease in overall mortality 
(Cladellas et al., 2012; Clevenger et al., 2016; Weltert et al., 2015). Overall, serious adverse 
events and mortality were not increased with the use of IV iron compared with oral or no iron or 
with the use of EPO, whether as single therapy or in combination with IV iron infusion (Litton et 
al., 2013; Yoo et al., 2011). It is important to note, however, that none of the studies included in 
this review found increased mortality. One study found an increased risk of all-cause infection 
associated with IV iron, but the authors admit that their result may have been a false positive and 
inconclusive due to the lack of associated infection in IV iron in other settings (i.e. dialysis, post-
surgical iron infusions) (Litton et al., 2013). 
The authors of all eight studies cited that iron supplementation with or without the use of 
EPO, or a single dose of EPO used separately, decreased the number of aRBCt per patient. 
Correcting anemia prior to surgery may decrease the risk of blood transfusion associated adverse 
events and shorten length of hospital stays (Cladellas et al., 2012; Clevenger et al., 2016).   
Model to Examine Phenomenon 
To help facilitate successful implementation and aid in sustaining the project, an 
implementation model guided the project execution. Conceptual models help to identify elements 
that are crucial to project success that may have otherwise been overlooked. The Promoting 
Action on Research in Health Sciences (PARiHS) framework (Kitson, Harvey, & McCormack, 
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1998) (see Appendix G) was used. The key elements of the PARiHS model are described in 
relation to this DNP project.  
PARiHS Model 
 Kitson et al. (1998) argue that successful integration of research into practice can be 
defined by the interplay of three core elements: level of evidence, the context or environment 
where research will be placed, and the facilitation process. Unlike other preceding theories on 
research implementation, Kitson et al. (1998) stipulates that all three elements should have equal 
standing. This model can be used as a checklist for users to assess needs prior to implementing 
research into practice.  
 The central caveat of this model is derived from the following equation: 
• SI = f(E, C, F) 
o Where SI = successful implementation, f = function of E = evidence, C = context, 
and F = facilitation. 
The premise of this model is that successful implementation is directly influenced by the 
relationship between the strength and nature of the available evidence, the context of the change 
environment, and the change mechanisms utilized. Kitson et al. (1998) suggests that all of these 
dimensions be considered simultaneously rather than in a hierarchy. 
 Evidence. Kitson et al. (1998) defines evidence as a synthesis of research, clinical 
expertise, and patient choice. Research quality may be low (anecdotal or descriptive) or high 
(RCTs, systematic reviews, evidence-based guidelines). Clinical experience is rated on a 
spectrum from high (consistent consensus) to low (divided opinion). Patient preference is rated 
by either the lack of patient involvement in healthcare or a partnership between healthcare 
providers and patients. For successful implementation of research that supports change, the 
evidence needs to be high quality, high consensus, and have high patient input. 
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 The evidence for IV iron in the treatment of anemia has been established in multiple 
systematic reviews and RCTs. Professional consensus on the adverse effects of blood 
transfusions and alternate therapies to avoid transfusions is also well established (Cladellas et al., 
2012; Clevenger et al., 2016; dos Santos et al., 2013). Patient input was considered in this change 
initiative. Providers are expected to educate and involve patients in the treatment plan and be 
available for questions or concerns.  
 Context. Context is the venue where the change will be implemented (Kitson et al., 
1998). Context is subdivided into three components: an understanding of the setting’s culture, 
the nature of relationships as seen through leadership roles, and how the organization measures 
its systems. Each of these three components runs along a range of high to low context. Culture is 
effective when the organization is patient-centered, appreciates employees, and values continued 
learning. Higher leadership consists of clear roles, effective teamwork, and clear structure. High 
context of measurement routinely utilizes internal and external performance measures.  
 As identified by the organizational assessment, there is a high level of context for this 
project. This project had a buy-in from leaders in organization. According to public information 
from the organization, a goal of MHS is to involve patients and families in their care and act with 
integrity, respect, and compassion. This organization is a teaching hospital that is open to change 
and ongoing learning. The proposed change project was welcomed at this organization. This 
project directly affected the cardiothoracic surgery group in the organization. This group was 
focused on quality measures and had well-attended, monthly meetings to discuss quality 
initiatives and how to improve the care they provide to patients.  
 Facilitation. Facilitation describes the behavior and support that is required to help 
people change their attitudes, skills, and ways of working (Kitson, et al., 1998). Successful 
facilitators must have strong attributes in three categories: characteristics, roles, and style. To 
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affect change, facilitators must be open, supportive, approachable, reliable, and have clarity 
around the facilitator role. Facilitators bring a personal set of skills as well as an ability to work 
within and across role boundaries in an organization (Kitson, et al., 1998). Even with high 
quality evidence and a context that is receptive to change, implementation may fail under non-
existent or ineffective facilitation.  
 The DNP student acted as the facilitator in this change project. A barrier to facilitation 
was identified during the needs assessment. This organization has an unclear process when 
ordering infusions in the outpatient setting. After discussion with key stakeholders, it was clear 
that the barrier may prove detrimental to the change intended within the project, if not addressed. 
The DNP student conducted meetings with key stakeholders to discover solutions to the problem. 
It was decided that a practice manager from the infusion center would provide education on how 
to order an infusion and provide a tip sheet to the PAC. The infusion center practice manager 
went to the PAC to educate providers in December 2018, prior to implementation. This manager 
assured the PAC that the infusion centers had the ability to see more patients and that infusions 
would be timely. Providers at the PAC expressed understanding of the process and found it to be 
more convenient than previously thought. The DNP student remained a resource for providers 
during the implementation process. To further assist in facilitation of this DNP project, the 
student remained respectful and flexible during the course of this project. Addressing concerns 
and being available is crucial during the beginning of and throughout the course of a change 
project. Remaining empathetic to the interruption of the workflow and required effort during a 
change in practice helped to foster trust between the facilitator and the healthcare providers.   
 Successful Implementation. Successful implementation occurs most often when 
evidence is high, the context is ready for change, when feedback mechanisms in place, and when 
there is facilitation (Kitson, et al., 1998). All three of these dimensions should be considered 
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equally when implementing a practice change. As previously stated, the evidence for this DNP 
project was high, consisting of systematic reviews and RCTs. An organizational assessment and 
a SWOT analysis of the outpatient preoperative assessment center were conducted to better 
understand the context and need for facilitation in the setting for this project. 
Project Plan 
Purpose of Project and Objectives  
The purpose of this project was to implement an evidence-based practice improvement 
initiative to improve the treatment of iron deficiency anemia prior to CABG surgery in a large 
MHS. The objectives for this project included: (1) conducting an organizational assessment of 
MHS to establish current state, (2) reviewing the literature to identify best-practice to treat iron-
deficiency anemia that has the potential to reduce blood products used in the perioperative 
setting, and (3) restructuring the current process within the setting to improve identification and 
treatment of iron deficiency anemia prior to cardiac surgery. This project sought to answer this 
clinical question: If patients are referred to a preoperative assessment center prior to CABG 
surgery for preoperative anemia work-up, will the number of patients entering CABG surgery 
without anemia treatment decrease? 
Design for the Evidence-based Initiative 
This was a quality improvement project. The phenomenon was examined using the 
PARiHS model. The initiative was based on the Kotter (1996) framework. The student 
considered the three core elements of the PARiHS framework when designing the project.  
Setting  
 Administrative approval to conduct the project at this facility was secured (see Appendix 
H). The DNP student implemented the project at the PAC associated with MHS. The PAC 
provides medical evaluation and optimization to assess risks prior to surgery. Typical 
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preoperative medical evaluation of patients is highly variable. In contrast, the PAC offers a 
standardized approach to preoperative medical evaluation and management to avoid preventable 
complications and mortality. In the current state, the PAC cared for orthopedic, bariatric, and 
vascular pre-surgical patients. There were four providers that service 3,800 patients a year; 
approximately half of the potential capacity. The goal for the PAC was to see all surgical patients 
in the health system in the next two to three years.  
Participants   
The project participants included the patients receiving the treatment for anemia and the 
healthcare providers in both the PAC and CTS offices. The scheduler for CTS, a medical 
assistant, were included to prep patient charts for surgeons prior to the initial consultation. The 
CTS scheduler worked with the PAC scheduler, a nursing technician, in scheduling patient 
appointments. The CTS surgeon performed the surgical consultation. The nurses in the CTS 
office were included to schedule the actual surgery and to educate patients on preoperative 
testing, if applicable. The healthcare providers in the PAC ordered the proper anemia treatment 
for the patients.  
Patients were identified for anemia treatment based on hemoglobin and mean corpuscular 
volume (MCV) levels prior to cardiac catheterization. Anemia is defined as a hemoglobin 
concentration of less than 12 g/dL in non-pregnant women and less than 13 g/dL in men (WHO, 
2008). MCV is the average size of red cells in a specimen (Curry, 2015). The MCV determines if 
an anemia is microcytic, normocytic, or macrocytic, as corrective therapy changes based on this 
result (Curry, 2015). The nurses in the CTS office ordered additional blood work for anemic 
patients based on their MCV from the blood work done pre-cardiac catheterization. The blood 
work was done prior to the appointment at the PAC so that providers had that information prior, 
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expediting the treatment process. Only anemic patients that were CABG candidates were 
included in this pilot project.  
Model Guiding Implementation 
 Kotter’s eight steps of change were used as a guiding framework to support this practice 
change (see Appendix I). Kotter (1996) created the model after 40 years of observing 
organizations as they were attempting to implement changes. There are three phases, which 
include eight steps that are needed to successfully implement change in an organization. These 
three phases include creating a climate for change, engaging and enabling the organization, and 
implementing and sustaining for change (Kotter, 1996).   
 Creating climate for change. The first phase consists of the first three steps to help the 
organization prepare for change. The first step is to establish a sense of urgency (Kotter, 1996). 
This requires the facilitator to help others recognize the need for change through a bold statement 
that inspires immediacy (Kotter International, 2018). The second step is to build a guiding 
coalition (Kotter, 1996). This coalition is made of leaders and effective people to sponsor and 
guide change (Kotter International, 2018). The third and final step in this first phase is to create a 
vision for change (Kotter, 1996). This involves clarifying how the change will affect the future 
and will guide people how to make the future a reality (Kotter International, 2018).  
 Engaging and enabling the organization. The second phase consists of the next three 
steps to enable the organization to change through communication and generating momentum. 
The fourth step is to communicate the vision (Kotter, 1996). Facilitators and leaders need to 
communicate the change throughout the organization. Change champions may assist in this 
effort (Kotter International, 2018). The fifth step is to empower action (Kotter, 1996). At this 
step, barriers to success need to be addressed and removed to promote action among the team 
members (Kotter International, 2017). The sixth step in the second phase is to create quick wins 
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(Kotter, 1996). Achieving and celebrating short term goals motivates team members and allows 
all to see that the change delivers results (Kotter International, 2018).  
 Implementing and sustaining for change. The third phase consists of the final two steps 
in the change process. The seventh step is to build on the change (Kotter, 1996). At this point, it 
is important not to let up as the first successes of the change are enacted in the organization. 
These successes must be used to accelerate improvements of systems and policies (Kotter 
International, 2018). The eighth and final step of the process is to “make it stick” (Kotter, 1996). 
This happens by ensuring that the new changes are strong enough to replace old habits and by 
ensuring that the new changes are integral to the success of the organization (Kotter 
International, 2018).  
Implementation Steps and Strategies 
 Implementation strategies for this project were selected based on the nature of the 
proposed project and the principles of Kotter’s Change Model (1996). A compilation of 
evidence-based strategies from Powell et al. (2015) was also used to guide the selection of 
specific implementation steps.  
1. Assess readiness and identify barriers and facilitators: When considering a potential 
quality improvement project, it is imperative that the DNP student first took the time to 
complete an organizational assessment (Moran, Burson, & Conrad, 2017). This enhanced 
project implementation, organizational change, and determine the potential for 
sustainability. This strategy guided the DNP student to assess various parts of the 
organization to determine the degree of readiness to implement and to identify barriers 
and strengths that may hinder or help the project succeed (Powell, et al., 2015).  
• From May through July 2018, the DNP student spent approximately 40 hours meeting 
with nursing managers, clinical practice managers, lead registered nurses of 
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outpatient clinics, and the CTS Renal and Blood Utilization Group. This helped the 
DNP student gain an understanding of the current state of anemia management. 
• From May through July 2018, the DNP student spent approximately 20 hours 
shadowing key stakeholders in their roles and holding meetings with appropriate 
personnel to assess the organization for readiness and willingness to change.  
• In August 2018, the DNP student met with the PAC practice manager to perform a 
SWOT analysis of the PAC. This included the internal strengths and weaknesses and 
its external opportunities and threats.  
2. Build a coalition/Identify early adopters: This strategy involves identifying and 
recruiting early adopters and cultivating positive relationships with key stakeholders 
(Kotter, 1996; Powell, et al., 2015).  
• From May to November 2018, the DNP student sought to build a positive relationship 
with the clinical practice manager of cardiovascular medicine at MHS. The manager 
is well connected and has introduced the student to key stakeholders.  
• In August 2018, the DNP student worked with the site mentor to recruit a small 
subcommittee of volunteers from the CTS Renal and Blood Utilization Group to 
assist in designing implementation strategies for the project. This small subcommittee 
included the DNP student, the practice manager, a quality improvement specialist and 
the quality manager for CTS. This group worked together to plan a process for 
anemia management in CABG patients (see Appendix J).  
• On October 5, 2018, the DNP student shared the process for anemia management to 
the subcommittee and with key stakeholders from CTS and the PAC. This included 
the division chief of CTS, the medical director of the PAC, cardiovascular operations 
director, the DNP student, quality improvement specialists, the clinical practice 
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manager serving as the mentor to this project, and the director of surgical services. 
This process included the approved algorithm for anemia management (see Appendix 
K). The process change was introduced to CTS surgeons in late October and was 
approved by this group. A meeting to operationalize the process took place in 
November 2018 with the manager of CTS, the PAC manager, the DNP student and 
the cardiovascular practice manager serving as a mentor.  
3. Develop and distribute education materials/Conduct educational meetings: 
Providing education materials allows stakeholders to learn about the new process and can 
serve as a passive reminder tool during implementation (Powell, et al., 2015). This 
includes holding meetings with stakeholders to teach them about the project (Powell, et 
al., 2015).  
• In November 2018, the DNP student and key stakeholders met to discuss the best 
strategies for provider education.  
• During the November 2018 CTS staff meeting, the DNP student and project mentor 
presented the project to the stakeholders.  
• During December 2018, CTS and PAC received information on the new PAC referral 
process and the anemia management order set. Information on workflow changes 
were provided. A tip sheet was designed to assist CTS staff in placing a referral to 
PAC and to assist in explaining the new process to patients (see Appendix L). 
4. Conduct tests of change: This implementation strategy allows for small, cyclical tests 
before change is trialed system-wide. The results of small tests can be used to gain insight 
before implementing on a larger scale (Powell, et al., 2015). 
• The pilot project started in December 2018. As part of current state, patients receive 
an order from the interventional cardiologist to have a complete blood count (CBC) 
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and basic metabolic panel drawn within one week prior to arriving to the cath lab. 
Patients were identified as surgical candidates by an interventional cardiology 
physician during the cath lab procedure if the patient’s heart disease is too advanced 
for cardiac stenting alone. Patients who were surgical candidates were then referred 
for surgical consultation. The registered nurse in the cath lab contacted the CTS 
scheduler who makes an appointment for the patient to see the cardiothoracic 
surgeon. 
• In December 2018, the pilot project started with patients of one surgeon with a 
CABG procedure. Another surgeon was added to the pilot for the last four weeks of 
implementation. Using the new process change, the CTS scheduler prepped the 
patient charts for the surgeons prior to the initial surgical consultation and identified 
anemic patients using the CBC drawn prior to the cath lab procedure. If the patients 
were anemic, the CTS scheduler collaborated with the PAC scheduler to make 
tandem appointments for the patient to see the surgeon and a provider at the PAC on 
the same day, when possible. The nurses in the CTS office then scheduled the surgery 
following the initial surgical consultation appointment, provided pre-surgery 
education for the patients, and then directed them to the PAC for their surgical 
optimization appointment. The CTS registered nurses in the surgeon’s office also 
ordered additional laboratory studies as indicated, including iron studies, vitamin B12 
levels, and folate levels. 
• From December 2018 through February 2019, patients with anemia were sent to the 
PAC for presurgical optimization. The nurse practitioners in the PAC ordered the 
necessary treatment for the patient’s anemia. Referrals to the infusion center were 
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made, if needed. The medical director and the nurse practitioners in PAC remained in 
contact with the surgeon. PAC followed each patient until the date of surgery.  
5. Audit and provide feedback/facilitate relay of clinical data to providers: This 
encompasses distributing performance data to key stakeholders over a specific period. 
This allows the student to provide feedback to providers, offers providers a tool for self-
evaluation, and provides quick wins during the practice change (Kotter, 1996; Powell, et 
al., 2015). 
• Key stakeholders received weekly progress reports on the project and updates on how 
the practice change was progressing. This included how many patients were treated 
per protocol, what they were treated with, and potential barriers that arose during 
implementation, with possible solutions.  
• The DNP student sought feedback from providers regarding facilitators and barriers 
identified during the project. Pre-implementation data were collected in November 
2018 for the period of August through October 2018. Post- implementation data was 
collected in March 2018 for the period of December 2018 to February 2019. 
• The DNP student collected measures using the STS data dashboard and through 
individual chart audit.  
6. Capture and share local knowledge: Disseminating the results of the DNP project is an 
evidence-based strategy and can assist other organizations to improve their systems 
(Powell, et al., 2015).   
• In March 2019, the DNP student shared final project results with key stakeholders.  
• CTS and PAC received a post-implementation satisfaction survey regarding provider 
satisfaction with the process change. This clarified any added value of project 
implementation and project sustainability (see Appendix M & N).  
PREOPERATIVE ANEMIA MANAGEMENT  
 
 
28 
• In April 2019, the DNP student provided a final report to MHS outlining project 
outcomes; and presented at the sites research council poster day on April 9, 2019. 
• In April 2019, the DNP student conducted final DNP project defense to disseminate 
further goals, sustainability options, and results; and published in ScholarWorks©.  
Measures 
 Measures are outlined below and shown in Appendix O: 
• Data were collected through chart audit included patient age, sex, presence of anemia 
diagnosis, hemoglobin prior to cardiac catheterization, referral to the PAC, presence of 
anemia treatment, type of anemia treatment, hemoglobin prior to surgery, presence of 
blood product usage, type of blood products used, if any, and hemoglobin after surgery.  
• The DNP student collected data from chart audits and using a tool (see Appendix P). 
Quality improvement specialists from cardiovascular services assisted the DNP student in 
collecting STS quality data.  
• Provider satisfaction is integral to the continued success of a process change. A post-
implementation survey regarding provider satisfaction with the process change was 
distributed after implementation, assisted by the PAC and CTS practice managers, to 
obtain information on project sustainability. CTS surgeons received a six-question survey 
in Likert format. PAC nurse practitioners received a five-question survey in Likert 
format. Both scales ranked answers from 1 “strongly disagree” to 5 “strongly agree” . In 
total, there were four surveys distributed and four surveys that were completed and 
returned. Each survey offered a comment section at the bottom.  
• The number of patients appropriately screened and treated per protocol for anemia prior 
to CABG surgery were analyzed pre- and post-implementation by chart audit. This 
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information identified whether the process change resulted in increased awareness of 
anemia and treatment prior to CABG surgery.   
• Use of perioperative blood products were measured during implementation to assess 
whether treatment of anemia resulted in a decrease in blood utilization. A comparison of 
a random sample of 10 patients not included in the pilot project were compared to 
patients in the pilot project. The DNP student obtained data from the MHS Blood 
Utilization Dashboard and through chart audit.  
• A global change in hemoglobin was measured in two groups: the average hemoglobin in 
10 patients not included in the pilot project were compared to patients in the pilot project. 
The data was obtained through chart audits.  
Data Collection Procedures 
The DNP student collected data for the project from the electronic health record (EHR) 
and STS quality data using a chart audit tool pre- and post-implementation in a Microsoft 
EXCEL spreadsheet. The pre-implementation audit was done in November 2018 and included all 
elective CABG surgeries from August 2018 through October 2018 (N = 54 surgeries). The post-
implementation audit was done in March 2019 and included a random sample of 10 patients not 
included in the pilot project and 14 patients in the pilot project, December 2018 through 
February 2019. Satisfaction outcomes with the new process for preoperative management of 
CABG patients was obtained by a Likert-style survey designed by the DNP student. The survey 
was piloted for clarity, then distributed to CTS surgeons and PAC providers in March 2019 post-
implementation with the assistance of the CTS practice manager.   
Data Management   
 The DNP student was responsible for data management throughout this project. After 
data collection was completed, the DNP student, in collaboration with a university statistician, 
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transferred the de-identified data to SAS for analysis. Data was stored on MHS internal drive that 
is only accessible by approved individuals (identified by health system administration). All 
protected personal information was removed to protect patient identity. Data remained on the 
drive upon completion of the project.  
Analysis  
 The data was analyzed with support from a university statistician. The proportion of 
patients entering surgery treated for anemia pre- and post-implementation were analyzed with a 
one sample test of proportions. The amount of blood products used in the perioperative setting 
pre- and post-implementation and average post-operative hemoglobin of CABG patients in the 
pilot group and the random sample of non-pilot group patients was analyzed using Wilcox Rank 
Sum test. Descriptive statistics were used to report satisfaction.  
Resources & Budget 
 The budget for the project is shown in Appendix Q. Resources needed for this project 
included the time and monetary compensation of key stakeholders and participants (Salary.com, 
2019). Resources such as computers and an electronic health record were already available at the 
organization. The main resource was compensation for time of stakeholders planning the project, 
time of staff during education, and the cost of anemia treatment.  
 The DNP student and GVSU statistician donated time for the project. Potential cost 
savings from this project include preventing the use of packed red blood cell transfusions in the 
perioperative period. At $761 ± $294 per unit, packed red blood cells are costly and are also 
potentially dangerous to patients (Shander et al., 2010). Packed red blood cells should not be first 
line for anemia in the perioperative period due to the associated complications (dos Santos et al., 
2013; dos Santos, et al., 2014).  
In a three-month period prior to the implementation of this project (August-October 
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2018), the majority of blood products used in surgery at MHS were used by anemic patients. In 
that three-month period, anemic patients in CABG surgery used 31 units of packed red blood 
cells while non-anemic patients used 17 units in that same period. The additional 14 units of 
aRBCt cost $10,654 (Shander et al., 2010). Any change in procedure that could reduce the use of 
packed red blood cells in surgery has proven to be potentially cost-saving and have a positive 
impact on patient outcomes (Cladellas et al., 2012; Litton et al., 2013; Weltert et al., 2015; Yoo 
et al., 2011).  
Timeline 
To ensure that the objectives of the project were met, Kotter’s eight-step change process 
(1996) served as a guide. See Appendix R for the proposed timeline. 
1. Establish sense of urgency: In September 2018, meetings with key stakeholders 
began. The DNP student met with clinical practice manager of cardiovascular 
medicine, quality improvement staff, and cardiothoracic surgery staff several times 
between September and October 2018 to begin planning the project. 
2. Build a guiding coalition: The DNP student identified additional key stakeholders in 
the PAC and within the cardiothoracic surgery office in September 2018. The PAC 
agreed to manage preoperative anemia with the surgeons.  
3. Create a vision for change: On October 5, 2018, a vision was created by the DNP 
student and clinical practice manager that defined the goals for the project. 
4. Communicate the vision: In October 2018, the process for managing anemia in 
CABG patients was presented to key stakeholders. The leaders of the surgical team of 
the PAC agreed to begin a pilot project on preoperative management in CABG 
patients. The finalized, proposed process was disseminated to the PAC, 
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cardiothoracic surgical office staff, providers, and interventional cardiologists. 
Education for these services was done in November and December 2018.  
5. Empower action: The new process for anemia management was incorporated into 
standard practice of one surgeon’s CABG-only patients by December 2018.  
6. Create quick wins: Weekly updates on the progress of the anemia management were 
disseminated via email to cardiothoracic surgery and to the PAC. Reinforcement of 
the new process was provided throughout this timeframe via site visits, emails, and 
dissemination at monthly quality meetings. 
7. Build on the change: Weekly progress reports continued throughout the 
implementation. A final review was provided for stakeholders by March 15, 2019. 
The anemia management process remained in place as standard work. The final 
review was presented to the CTS Quality Subcommittee in April 2019. 
8. Make it stick: The anemia management process was expanded into other 
cardiothoracic procedures and other surgeons.   
Results 
Twenty four patients divided into an intervention (n=14) and usual care (n=10) group 
were analyzed. The intervention group were 14 patients that were screened using the new referral 
process. The usual care group was a convenience sample of 10 patients that were not involved in 
the new referral process. The average age of Intervention group was 63.8 (Standard Deviation 
9.8 [SD]) years and 68.8 (SD 9.7) years in the usual care group. The intervention group were 
21.4% (3 of 14) female and usual care were 10% (1 of 10) female.  
Patients Screened for Anemia 
CABG patients of one CTS surgeon were screened for anemia for all 12 weeks of 
implementation using the new referral process. Another surgeon’s CABG patients were trialed 
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for the last four weeks of implementation. Of those in the intervention, 42.9% (6 of 14) were 
anemic at the initial CTS consultation. Of those with anemia 83.3% (5 of 6) patients were 
properly screened and referred to the PAC where they were evaluated. The one remaining patient 
was not identified and was not referred and did not receive treatment for anemia prior to surgery. 
Incidentally, this patient was no longer anemic at the time of surgery. Of the 20% (1 of 5) of the 
patients referred to the PAC did not receive treatment for anemia as the patient’s hemoglobin 
levels were considered to be baseline normal for that particular patient and care was 
subsequently individualized.  
In total, 66.6% (4 of 6) patients who were anemic, were identified and treated compared 
to only 17% (7 of 41) of anemic outpatient CABG patients who were identified as anemic prior 
to surgery in the pre-implementation (D’Agostino et al., 2018). Following implementation, the 
proportion of patients f treated for anemia were statistically greater than pre-implementation 
(p=.0006). Overall, there was a 49.6% increase in anemic patients receiving treatment prior to 
surgery when pre- post-implementation were compared (see Appendix S). Incidentally, one 
patient in the intervention group who was not anemic was prescribed EPO injections 
preoperatively due to an inability to receive blood products during surgery. 
Use of Perioperative Blood Products 
The median blood products used in the intervention group were 1.5 units compared to 2 
units in the usual care group. In the intervention group 42.9% (6 of 14) received blood products, 
or 14 units of aRBCt. One unit of platelets was also used in Intervention group. Compared to 
usual care, where 50% (5 of 10) received blood products, or 6 units of aRBCt. Other types of 
blood products used include platelets (3 units) and cryoprecipitate (1 unit). While the 
intervention group used more units of aRBCt, a higher proportion of patients who had usual care 
received blood products. It should be noted that one patient received seven units of aRBCt in 
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thee intervention group, skewing the data. After completing within and between analysis, 50% (5 
of 10) of the intervention group received blood compared to 42.9% (6 of 14) in the group that did 
not receive the intervention (p-Value = 1), showing no significant difference. Blood usage data is 
shown in Appendix S.  
Change in Hemoglobin 
The intervention group had 42.9% (6 of 14) who were anemic at the time of their first 
CTS surgical consult. One anemic patient was not referred nor treated, but was no longer anemic 
in the perioperative period, leaving 35.7% (5 of 14) anemic at the time of surgery. In the usual 
care group 20% (2 of 10) patients were anemic at time of their first CTS surgical consult. One 
patient that was not anemic at the time of the initial consult became anemic in the perioperative 
period, increasing to 30% (3 of 10) at the time of surgery.  
The total average post-operative hemoglobin of all patients in the intervention group was 
10.3 g/dL compared to 10.1 g/dL in the usual care group. There is not sufficient evidence to say 
that the distribution of post-surgical hemoglobin differs between the groups were significant 
(p=0.62). In the anemic patients, the total average post-operative hemoglobin in the intervention 
group was 9.27 g/dL compared to 10.0 g/dL in the usual care group.  
Provider Satisfaction: Survey Results 
Two CTS surgeons and 2 nurse practitioners at the PAC that were involved in the pilot 
project received the post-implementation survey (see Appendix M and N). The surveys for the 
CTS surgeons and PAC nurse practitioners are discussed separately below.   
CTS Survey. This survey consisted of six questions. Both surgeons answered neutral or 
favorably to four questions. The second question “The referral process between the PAC and 
CTS was easy to navigate” was answered with a “5” from Surgeon 1 and a “2” from Surgeon 2. 
The fifth question “The communication between the PAC and CTS has met my expectations” 
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was answered with a “2” from Surgeon 1 and a “3” from Surgeon 2. Five questions were 
answered with a neutral or above-neutral average. The fifth question had an average Likert scale 
answer of 2.5, below neutral. The sixth question of this survey was related to sustainability. 
When asked, “,” both surgeons answered a “4,” or “Agree.” The graphic depiction of survey 
responses for CTS Surgeons can be found in Appendix T. 
PAC Survey. This survey consisted of five questions. Both providers answered neutral or 
favorably to four questions. The first question, “This process change had no impact on my 
workflow” was answered with a “3” from Provider 1 and a “2” from Provider 2. The average 
answer of four questions was neutral or above-neutral. The first question had an average Likert 
scale answer of 2.5, below neutral. The last question related to the sustainability of this referral 
process. When asked, “I recognize the benefit of this referral process and am likely to continue to 
support it,” both providers answered “4” or “Agree.” Provider 2 offered these comments on their 
survey: "It took about [three] days with the last order for IV iron – "pending approval" before it 
turned to authorized and patient was contacted. Also patient referred within [two] weeks of 
surgery, so was only going to get [one] infusion [of IV iron]." The graphic depiction of survey 
responses for PAC providers can be found in Appendix T. 
Discussion  
The results suggest that the new process increased awareness of preoperative anemia and 
treatment with 50% of patients receiving care as expected. Four of the six patients who were 
identified as anemic were treated prior to surgery, at a rate of 66.6%. This is a statistically 
significant increase from the pre-implementation rate of 17% (p=.0006); in the pre-
implementation period, only one of the six identified anemic patients (17%) would have been 
treated. Based on the results of the time limited project and the small pool of patients, this new 
referral process increased awareness of anemia treatment and decreased the number of anemic 
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patients who entered CABG surgery without anemia treatment, thereby improving the quality of 
patient care. This is similar to findings of the others (Edwards & Slawski, 2016). 
 Blood product usage was increased in our intervention group; however, it was noted that 
one patient in Intervention group used seven units of aRBCt and this may have skewed the data 
for. Excluding this patient, Intervention group used six units of aRBCt and Group 2 used five 
units of aRBCt. When examining the proportion of patients who used blood products, however, a 
smaller proportion of patients in Intervention group (42.9%; n=6) received any type of blood 
product while a larger proportion of Group 2 (50%; n=5) received blood products. This may be 
due to an increased awareness of the cost of aRBCt; in dollars, and in patient outcomes 
(Cladellas et al., 2012).  
The average post-surgical hemoglobin of intervention group (10.3 g/dL) was higher than 
that of the usual care group (10.1 g/dL). This is not statistically significant, but it is clinically 
meaningful (p=0.6227). The intervention group had a higher average post-operative hemoglobin 
than the usual care group, even though more patients that were anemic (42.86% versus 20%). 
There may be other factors that contributed to this, but it may be that treating anemia prior to 
surgery could have had a positive effect on the post-operative hemoglobin in intervention group. 
This slight rise in hemoglobin in the intervention group, despite the higher number of anemic 
patients, is one reason to continue the referral process that results in more patients being treated 
for anemia.  
Several colleagues recommended iron-deficient patients be treated with IV iron infusions 
prior to surgery to improve hemoglobin recovery after surgery and to reduce the risk of aRBCt in 
the perioperative period (Clevenger et al., 2016; Lin et al., 2013; Litton et al., 2013). In this 
project, two of the four patients were treated with IV iron. The other two patients were treated 
with oral iron supplementation. Oral iron has been shown to increase hemoglobin concentration, 
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but not as well as IV iron infusions (Clevenger, et al., 2016; Gurusamy et al., 2014; Litton et al., 
2013). Had all applicable patients in Intervention group been treated with IV iron, it is possible 
that post-surgical hemoglobin and blood product usage may have more noticeably changed.  
In order to determine if iron infusions are successful in increasing hemoglobin, iron 
levels are drawn one month following the last iron infusion. This information was not available 
in most cases in this project. One patient that received iron infusions prior to surgery had a 
longer wait time between the last iron infusion and surgery than average (three weeks for this 
pilot project). This patient’s time between the last iron infusion and surgery was six weeks. In 
that time, the patient’s pre-iron infusion hemoglobin of 9.1 g/dL rose to 11.4 g/dL just prior to 
surgery. This robust hemoglobin change is consistent with findings from the literature 
(Clevenger et al., 2016; Gurusamy et al., 2014; Litton et al., 2013; Peters et al., 2018). 
Post-implementation surveys were distributed to clarify sustainability and added value of 
this new referral process. In general, the satisfaction surveys were answered favorably, but some 
concerns were noted. One provider at the PAC stated that the process changed work flow. The 
provider was not specific on how the process changed their work flow and if this change was 
negative or positive. Both PAC providers expressed some trepidation regarding the ease of 
ordering iron infusions in the EHR. They found that the insurers were slow to authorize the iron 
infusions and that patients were not always contacted in a timely manner for an appointment by 
the infusion center, resulting in delayed patient care. However, all four providers were willing to 
continue with the new referral process and answered favorably regarding added value.  
Notably, ease of the referral process responses were disparate for both CTS and PAC. 
Navigating the referral process proved difficult for one surgeon and communication between the 
two offices lacked efficiency for the other surgeon. One surgeon found the process very easy and 
the other surgeon found it difficult. The surgeon who found the process difficult was only 
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involved in the process for four weeks, rather than the entire implementation period, which may 
have contributed to this rating. Similarly, the provider at the PAC who found the referral process 
easier than their counterpart was involved for a longer period of time in the project. These 
responses suggest a correlation between the time involved in the process and the perception of 
ease for the new referral process. 
There were some differences noted between the original, proposed budget and the actual 
final budget. The original budget noted a potential savings of $10,654, based on data available 
for the three months prior to implementation. In that three-month period, anemic patients in 
CABG surgery used 31 units of packed red blood cells while non-anemic patients used 17 units 
in that same period. These numbers include surgeries performed by all CTS surgeons at MHS. 
The additional 14 units of aRBCt cost $10,654 (D’Agostino et al., 2018; Shander et al., 2010).  
Anemic patients, predictably, used more blood products than do non-anemic patients in 
the three-month period prior to this implementation. This project also had a smaller sample size. 
This is mostly due in part because there are fewer CTS surgeons involved than originally 
anticipated. Seven surgeons were originally predicted to be involved. The management at CTS 
elected to start this project with only two surgeons, rather than seven. So two surgeons’ patients 
were ultimately included in the pilot. Achieving a cost savings of over $10,000 is not feasible 
when the actual sample size is so much smaller than the predicted size. In this small pilot project, 
there was not a significant change in blood usage between the intervention group and usual care. 
There was a potential for cost-savings as originally predicted; however, one patient in the 
intervention group used seven units of aRBCt, which skewed the data. This project did not 
investigate any other cost saving measures, such as length of stay. Evidence has shown that 
correcting anemia to reduce use of aRBCt will positively affect the length of stay (Cladellas et 
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al., 2012; Clevenger et al., 2016). Further investigations into how anemia can adversely affect 
length of stay for CABG patients are needed in the future.  
An unintended positive consequence of this project was that patients were referred to a 
preoperative assessment center that specialized in pre-surgical optimization of chronic diseases. 
The patients that were referred also received close assessment of their other chronic diseases, 
which may have resulted in better optimization on the whole. The screening and treatment of 
preoperative anemia in CABG surgery increased due to the relationship between CTS and PAC. 
The results of post-implementation provider surveys indicate that this process is sustainable.  
Limitations 
Limitations of this project include the following. This project had a short implementation 
period and also had to function within the constraints of the organization. The organization 
required that this project start with only one surgeon’s CABG-only patients, rather than trialing 
the entire group of cardiothoracic surgeons. This resulted in a small sample size. The sample size 
made it difficult to evaluate statistical significance.  
 During the implementation period, the staff member who prepped the charts for CTS 
went on leave, requiring another staff member to take over the duties of that position as well as 
their own. The staff member that went on leave was involved in the pilot project from the 
beginning and was invested. The new staff member was not as involved and was not as invested. 
This resulted in patient’s receiving a delayed referral to the PAC and a postponement of required 
treatment for anemia. Even though the DNP student was present in the CTS office to assist, there 
remained one patient referral fallout. Efforts to minimize limitations included close facilitation 
by the DNP student in both the CTS and PAC offices. Weekly email updates were used to 
energize staff on the status of the project and to celebrate successes.  
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Examining the data, one patient alone received seven units of aRBCt in Intervention 
group. That patient acts as an outlier and skews the data for Intervention group, making analysis 
difficult. Post-operative hemoglobin was measured immediately after surgery. Per the anemia 
algorithm in Appendix K, hemoglobin levels will show change after approximately one month 
after the completion of iron therapy, however, this data was not available for this project.  
Perioperative blood loss per patient was not collected. This information may have 
provided insight on the relationship between blood loss and blood product usage. It may have 
shown a correlation to what degree of perioperative blood loss is related to the transfusion of 
blood products. It is noted that in a study that measured blood loss in 200 patients, average blood 
loss in CABG surgery was around 500 milliliters (Bjessmo & Ivert, 2000).  
Finally, nurses and support staff in the CTS office were not surveyed, making the survey 
information incomplete. This information may have provided a more complete look at how the 
new process was perceived.  
Sustainability Plan 
 The results of this project were presented to the CTS Quality Subcommittee in their 
monthly meeting in April 2019. Key stakeholders within the organization and in cardiothoracic 
surgery have discussed further applications of this project model in different cardiac surgeries 
and in conjunction with the PAC. After a discussion with CTS and PAC leaders, the referral 
process will remain in place after the completion of this project. There is buy-in by key 
stakeholders. The high involvement and buy-in from leadership and the quality of evidence are 
strong indicators that this project is sustainable. There is also a possibility of a future DNP 
student continuing this work with other surgical teams to assist in the implementation of a more 
congruent preoperative optimization. 
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Dissemination of Results 
 Dissemination of results occurred with key stakeholders of CTS on April 10, 2019 at 
MHS. The final results were also shared with providers, the medical director, and the nursing 
manager at the PAC. The final product of this project was presented at the university in front of 
the DNP student’s advisory team and other members of the community who chose to attend on 
April 15, 2019. The final draft of the project paper was uploaded to ScholarWorks© and can be 
accessed by any interested party. This project was presented at MHS at an open forum poster 
showcase in April 2019. The DNP student was available for organization leaders and community 
members to answer questions and to explain the scope of the project. 
Implications for Practice and Further Study in the Field 
This project has multiple implications. Preoperative anemia can, and should, be treated. 
Evidence suggests that treating preoperative anemia can positively impact patient outcomes and 
is a cost-effective alternative to aRBCt in the perioperative period (Clevenger et al., 2016; 
Gurusamy et al., 2014; Litton et al., 2013; Peters et al., 2018; Shander et al., 2010). Evidence 
from this project also suggests that referring patients to the PAC can have a positive impact on 
anemia management.  
 Referring patients to the PAC proved to be a success in the treatment of iron deficiency 
anemia. Anemia that would otherwise have not been recognized was treated prior to surgery. 
Continuing to refer patients to the PAC will result in continued treated of anemia and will also 
involve close follow-up on other chronic conditions that may affect surgical outcomes. The PAC 
staff have a close relationship with many surgical entities in MHS and CTS patients can benefit 
from their expertise. The relationship between the PAC and CTS to treat anemia is not a static 
affiliation, but something that will need to be continuously managed.  
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Conclusion  
Treating preoperative anemia in the CTS population is a focus of the CTS group at MHS. 
An organizational assessment revealed that preoperative anemia is prevalent in about 30% of all 
CTS patients at MHS. Preoperative anemia is currently undertreated at this organization resulting 
in increased use of aRBCt, which can result in negative outcomes after surgery. A literature 
review of treatment for preoperative anemia was conducted to identify best-practice 
interventions for the treatment of anemia for use at MHS. Evidence revealed that treating anemia 
prior to cardiac surgery can reduce the use of aRBCt in the perioperative period and lead to a 
decrease in mortality (Cladellas et al., 2012; Clevenger et al., 2016; Weltert et al., 2015). CTS 
partnered with a preoperative assessment center optimize comorbid conditions prior to surgery 
and to treat preoperative anemia in CABG patients. One CTS surgeon was asked to refer his 
anemic patients to the PAC for treatment and surgical optimization. This one surgeon referred 
his anemic, elective CABG patients for a full twelve weeks. Another CTS surgeon was added to 
the pilot for the last four weeks of implementation. Implementation resulted in five patients 
being referred and treated for anemia.  
Results revealed a statistically significant increase in the number of patients who were 
treated for anemia prior to CABG surgery. There was no change in blood product use, but data 
did reveal a lower proportion of patients who used blood products in the pilot group. This may be 
interpreted as an increased awareness of the cost of aRBCt, not only in dollars, and improving 
the quality of patient care. There was a clinically significant rise in post-operative hemoglobin 
between the pilot group and the random sample of patients. This result was not statistically 
significant, but it could be said that increased awareness and treatment of anemia prior to surgery 
may have had a positive effect on the post-operative hemoglobin in the pilot group. The surveys 
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for both CTS and PAC showed that all providers were willing to continue to support the new 
referral process for treating anemia in outpatient CABG patients.  
The potential cost savings to patient quality of life by avoiding perioperative adverse 
effects relating to anemia and the cost of a unit of blood ($761 ± $294 per unit) are also 
important factors to consider (Shander et al., 2010). The referral of these patients to the PAC for 
their anemia also resulted in increased surveillance of their comorbid health conditions in the 
perioperative period. The treatment of anemia prior to surgery is best practice and evidence has 
shown that it improves outcomes after surgery. 
Reflection on DNP Essentials 
The American Association of Colleges of Nursing (AACN) requires that all DNP 
students be proficient in the eight foundational competencies for advanced practice registered 
nurses (AACN, 2006). Each essential was met throughout the development, implementation, and 
dissemination of this DNP project and is reviewed below.  
Essential I: Scientific Underpinnings for Practice 
 Addressing current and future practice issues requires a strong scientific educational 
foundation. DNP graduates are prepared with a wide array of knowledge that is gleaned from 
social and natural sciences. DNP graduates have the ability to translate that knowledge quickly 
and effectively (AACN, 2006). This essential was achieved through this project in a number of 
ways. In the course of this project, the DNP student performed a literature review on anemia and 
best practice for treatment of perioperative anemia and applied those findings to a quality 
improvement project. Knowledge of the organizational problem related to the management of 
anemia in patients scheduled for CABG surgery was gleaned from clinical experts in the 
organization. Clinical experts were consulted through personal meetings. In addition, the 
PARiHS framework guided the implementation of the referral process to treat anemia. This 
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framework focuses on evidence, context, and facilitation (Kitson, et al., 1998).  
Essential II: Organizational and Systems Leadership 
 Organizational and systems leadership skills are critical for DNP graduates to improve 
patient and healthcare outcomes. Doctoral level knowledge and skills in these areas contribute to 
the effort to eliminate healthcare disparities and to promote excellence in practice (AACN, 
2006). The DNP student demonstrated organizational leadership by first meeting with leadership 
and performing an organizational needs assessment. This allowed the student to create a project 
that best met the organization’s needs. The DNP student used communication skills learned from 
the DNP program to lead this quality improvement initiative and negotiate the change process 
and gain buy-in from key stakeholders. This project addressed the need to treat perioperative 
anemia before cardiac surgery. Communication with leadership at both the PAC and CTS 
occurred frequently and through the use of email, conference calls, and in-person meetings. 
Budgetary issues and health policy discussions occurred frequently with the cardiovascular 
medicine manager, the CTS manger, and with the CTS clinical program specialist. Costs for 
patients and for the organization were discussed during project formulation as well.  
Essential III: Clinical Scholarship and Analytical Methods 
 Research is a hallmark of doctoral education, but this essential focuses on the application 
of research into practice and the dissemination and incorporation of new knowledge. These are 
key attributes of the DNP graduates (AACN, 2006). Nursing exemplifies the relationship 
between research application, science, and human needs. This quality improvement pilot project 
was aimed at increasing anemia management in the cardiac surgical population as per best 
practice guidelines. This new referral process will help to improve treatment of anemia in the 
practice setting. 
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Essential IV: Information Systems/Technology 
 DNP graduates are able to use their abilities as leaders to use information technology to 
support and improve patient and healthcare system outcomes (AACN, 2006). DNP prepared 
nurses can use information systems to evaluate outcomes of care, care systems, and programs 
within the systems. Technology offers a way to apply budget and productivity tools, support 
decision, and foster learning to improve the care of patients (AACN, 2006). A quality dashboard 
to monitor blood usage at MHS was used frequently to inform the DNP student of any change in 
blood usage through the course of this pilot. Information technology was used as a tool to collect 
data throughout project implementation.  
Essential V: Advocacy in Health Care Policy 
 Policy, whether it be organizational or in the government, provide a framework to 
facilitate the delivery of healthcare services. DNPs need to be engaged in healthcare advocacy to 
have a voice in policies that will affect the workplace and the patients that are served (AACN, 
2006). Activism and commitment to policy development are central caveats to professional 
nursing practice and the DNP has an ability to be a leader in advocacy (AACN, 2006). During 
the course of the project, the DNP student took into account standard practice at the CTS office 
and the general policies and procedures of the organization as a whole. While this project did not 
involve any policy change, the goal was to move practice towards best practice for anemia 
treatment according to existing guidelines.  
Essential VI: Interprofessional Collaboration 
 The healthcare environment of today requires contributions from individuals in multiple 
different professions. In order to accomplish safe, equitable, effective, and efficient patient care, 
healthcare professionals must function as a team. DNP graduates are prepared to lead and 
collaborate with different professionals in a complex environment to achieve goals (AACN, 
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2006). The DNP student collaborated with many different disciplines in the CTS office, the 
PAC, and in cardiovascular medicine throughout the course of this project. Different disciplines 
that are integral to the progress of this project included surgeons, nurses, nursing managers, 
quality improvement specialists, pharmacists, statisticians, and faculty members. The student 
worked closely with providers at both the PAC and CTS to provide education during 
implementation and to answer questions.  
Essential VII: Clinical Prevention Population Health  
 DNP graduates are prepared to engage in leadership to integrate evidence-based clinical 
prevention and population health services for individuals and the whole population. The DNP is 
prepared to promote clinical prevention to individual patients and is prepared with a foundation 
in population health (AACN, 2006). Concepts of public health concerns, health promotion, social 
determinants of health, and promoting cultural diversity guide the practice of the DNP (AACN, 
2006). The student evaluated specific organization data related to the anemia status of CABG 
patients at MHS. This project was geared to improve the health status of patients in this specific 
population. The environmental and cultural needs of the organization and this group of patients 
were considered in the formulation of this pilot project.  
Essential VIII: Advanced Nursing Practice 
 Due to the growth in specialization in the nursing field, no individual can master all 
advanced roles and the required knowledge for enacting these roles. DNP programs provide 
preparation within distinct specialties and mastery in one area (AACN, 2006). A DNP graduate 
is prepared to practice in and have mastery in one area of specialization; this is the hallmark of 
the DNP (AACN, 2006). DNP programs provide learning experiences that are based in a variety 
of patient care settings and are integrated throughout the whole program. These learning 
experiences help to inform future practice decisions. The student developed many partnerships 
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during the course of this project. These partnerships exist between the DNP student and members 
of the organization as well as between two entities at MHS, the PAC and CTS. The DNP student 
was integral to the beginning of and the continuation of this relationship. The DNP student was 
available for questions and to facilitate other staff members in this implementation period that 
resulted in positive change for preoperative anemia management for elective CABG patients at 
MHS. 
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Appendices 
Appendix A 
The Burke and Litwin Model of Organizational Performance and Change 
 
 
A model of organizational performance and change. Reprinted from “A causal model of 
organizational performance and change,” by W. W. Burke and G.H. Litwin, 1992, Journal of 
Management, 18(3), 528. Copyright 1992 by Southern Management Association.  
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Appendix B 
Organization IRB Determination 
 
Available upon request.  
 
  
PREOPERATIVE ANEMIA MANAGEMENT  
 
 
54 
Appendix C 
GVSU IRB Determination 
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Appendix D 
SWOT Analysis of the Preoperative Assessment Center 
 
 
   
Strengths 
• Aesthetically pleasing building 
• Part of a Magnet designated hospital 
system 
• Motivated leaders and staff that 
support change projects. 
• Consistent providers that specialize in 
preoperative assessment 
• Close relationship to the hospital 
where surgeries take place 
• Cohesive pre-surgical optimization 
visit 
Weaknesses 
• Gaps in needed staff; need pharmacy, 
dietician, and more advanced practice 
providers 
• Lack of infusion chairs readily 
available 
• Need additional staff to provide more 
in-depth education classes.  
Opportunities 
• Blood shortage, need for management 
to decrease the use of blood products 
• Has bandwidth to see more patients 
• Close relationship with hospitalists 
and referring providers and anesthesia, 
leads to effective communication 
streams 
• Enhanced quality of care by 
incorporating evidence-based practice. 
• A positive relationship between the 
PAC practice manager and a local 
infusion center  
Threats 
• Individual barriers to change, 
unwillingness to change 
• Ordering infusions perceived as 
confusing process at this organization 
• No current relationship with 
cardiothoracic surgery. 
• Patients unable to get to infusion 
clinic/pay for new iron infusion 
supplements.  
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Appendix E 
PRISMA Flow Diagram of Systematic Search 
 
PREOPERATIVE ANEMIA MANAGEMENT  
 
 
57 
Appendix F 
Table of Evidence  
Articles included in review with author, year, purpose, design, inclusion, intervention comparisons, results, conclusions  
Author (Year) 
Purpose 
Design (N) Inclusion Criteria Intervention vs 
Comparison 
Results Conclusion 
Yoo (2011) 
Investigate 
effect of a 
single 
preoperative 
bolus of 
erythropoietin 
(EPO) on 
perioperative 
transfusion 
requirement  
Prospective, 
single-site, 
single 
blinded, 
randomized, 
and parallel-
arm 
controlled 
trial N=74 
Adults with 
preoperative 
anemia  
500IU/kg EPO and 
200mg iron sucrose IV 
1 day before surgery. 
The control group 
received an equivalent 
volume of normal 
saline.  
Assessed transfusion 
requirement during 
surgery and 4 days 
postop. Reticulocyte 
count and iron profiles 
were measured 
serially and compared 
preoperatively and on 
post-op days 1, 2, 4, 
and 7.  
-Transfusion occurred in 86% of the 
control group versus 59% of the 
EPO group. 
-The mean number of packed red 
blood cells transfused per patient 
and for 4 postoperative days was 
decreased in EPO group versus the 
control group (3.3 ± 2.2 vs 1.0 ± 1.1 
units/patient). 
A single IV 
administration of 
EPO and an iron 
supplement 1 day 
before surgery 
reduced 
perioperative 
transfusions in 
anemia patients 
undergoing 
valvular heart 
surgery  
Cladellas 
(2012) 
Investigate 
whether the 
combined 
therapy (IV 
rhEPO and 
iron) before 
valve 
Before-and-
after study: 
RCT (Total 
N=134; , 
anemic adults 
Anemic adults 
without 
emergency 
surgery, isolated 
CABG 
-Intervention started 
1-month prior to 
surgery, 500IU/kg/day 
rhEPO was given 
every week for four 
weeks and the fifth 
dose 48 hrs. before 
surgery. During each 
rhEPO session, 
-Therapy increased hemoglobin 
concentration from 11.2 ± 1g/dL at 
baseline to 12.6 ± 0.9 g/dL before 
surgery.   
Combined therapy 
of IV rhEPO and 
iron administered 
before cardiac vale 
replacement in 
anemic patients 
improved in 
postoperative 
outcomes and 
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replacement 
improved 
postoperative 
mortality and 
morbidity; and 
extent to which 
aRBCt were 
decreased. 
patients received iron 
infusion 
supplementation (max 
dose 200mg/day, 
calculated by body 
weight). Therapy was 
stopped if hemoglobin 
levels reached normal. 
decreased in RBC 
transfusions 
Lin (2013) 
Assess IV iron 
efficacy to 
reduce 
perioperative 
red cell 
transfusions. 
Systematic 
review: 24 
RCTs and 15 
non-
randomized 
trials 
(N=4,417)  
 Adults with 
anemia scheduled 
for surgery, who 
were not pregnant  
-Use of EPO and 
IV iron in mgmt. 
of perioperative 
anemia 
-IV iron on anemia 
-EPO on anemia 
-EPO + IV iron on 
anemia 
- A short preoperative regimen of 
EPO, or a single dose of EPO plus 
IV iron in the preoperative or 
intraoperative period may 
significantly reduce transfusion 
rates (number needed to treat to 
completely avoid RBC transfusions 
ranged from 3 to 6 infusions.) 
-Patients with 
preoperative iron 
deficiency anemia 
may have an earlier 
and more robust 
hemoglobin 
recovery with 
preoperative IV 
iron therapy than 
with oral iron 
supplementation.  
 
Litton (2013) 
Evaluate 
efficacy/safety 
of IV on 
hemoglobin, 
requirement 
for transfusion, 
and risk of 
infection 
Systematic 
review/meta-
analysis (75 
RCTs 
N=10,879) 
RCTs of IV iron 
compared with 
either no iron or 
oral iron 
 
-Change in 
hemoglobin 
-Infection  
-Transfusion  
-Serious adverse event 
-Mortality  
-Increased standardized mean 
hemoglobin concentration compared 
with oral iron or no iron 
supplementation (standardized mean 
difference 6.5 g/L, 95% confidence 
interval 5.1 g/L to 7.9 g/L)  
-Reduced risk for blood transfusion 
(risk ratio 0.74, 95% confidence 
interval 0.62 to 0.88) 
-Reduced risk ratio of requiring red 
blood cell transfusion after IV iron 
therapy.  
IV iron increased  
 hemoglobin 
concentration and 
reduced risk of 
allogeneic red 
blood cell 
transfusion 
Gurusamy 
(2014) 
Cochrane 
Review (21 
Adults with mild-
moderate anemia 
who were not 
-PO iron vs inactive 
controls 
-Required blood transfusions was 
reduced from 27.9% in the inactive 
-Oral iron 
decreased those 
proportion of 
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Assess the 
safety and 
efficacy of iron 
therapies for 
the treatment 
of adults with 
anemia   
RCTs, 
N=4745) 
pregnant/have 
kidney disease 
-IV iron vs inactive 
controls (oral or IV 
placebo)  
-Compared different 
iron preparations.  
control group versus 20.6% in the 
oral iron group 
-Required blood transfusions was 
reduced from 18.2% in the inactive 
control group versus 15.3% in the 
IV iron group 
-Required blood transfusions was 
reduced from 18.9% in the oral iron 
group versus 11.5% in the IV iron 
group 
-Hemoglobin in the oral iron group 
was 0.3 to 3.10 g/dL higher than the 
inactive control group.  
-Hemoglobin in the IV iron group 
was 0.3 to 3.00 g/dL higher than the 
inactive control group.  
-Hemoglobin in the IV iron group 
was 0.5 g/dL lower than the oral 
iron group. 
people who 
required blood 
transfusion. 
-IV iron results in 
a modest increase 
in hemoglobin 
levels compared to 
oral iron or 
inactive control 
without clinical 
benefit.  
Weltert (2015) 
Assess single 
80,000IU dose 
of human 
recombinant 
erythropoietin 
(HRE) 2-days 
before cardiac 
surgery effect 
on reducing 
perioperative 
allogeneic red 
blood cell 
transfusion. 
Prospective 
single-blind 
RCT 
-Antiplatelet 
and 
anticoagulati
on stopped 5-
days prior to 
surgery. 
-Trigger 
hemoglobin 
level to 
transfuse: 8.0 
-Adults 
undergoing heart 
surgery at the 
European Hospital 
in Rome, Italy 
with a hemoglobin 
of less than 14.5 
g/dL 
-Received HRE vs 
none 
-Hemoglobin Baseline 
vs post-operative day 4 
-Baseline ferritin and 
transferrin values to 
assess preoperative 
iron metabolism.  
-HRE related adverse 
events 45-days’ post-
surgery. 
-17% (51/300) in HRE group 
required PRBCs compared to 39% 
(117/300) in the control 
-HRE reduced the risk of PRBCs 
44% compared to control.  
-Low rate of potential HRE related 
adverse events including infection, 
thrombosis, hypertension, and renal 
or neurologic complications. 
-Mortality was similar between two 
groups.  
Single high dose 
of HRE 
administered 2-
days before 
cardiac surgery 
reduced need for 
PRBCs without 
increasing adverse 
events, reducing 
transfusions.  
Clevenger 
(2016) 
Cochrane 
Review (64 
-RCTs irrespective 
of blinding, 
-Oral iron vs placebo 
or no iron therapy 
-Oral and IV iron demonstrated 
reduction in the risk of blood 
IV iron improved 
hemoglobin 
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Assess efficacy 
and safety of 
iron therapies 
for adults with 
anemia 
RCTs, 
N=9,004) 
publication status 
or date, study 
setting, and sample 
size.  
-Any non-
peripartum anemic 
adults without 
CKD 
-IV iron vs placebo or 
no iron therapy 
-IV iron vs oral iron 
-Various oral iron 
formulations and 
doses compared to 
each other 
- Various IV iron 
formulations, routes 
(IM vs IV) and doses 
transfusion when compared with 
inactive control (risk ratio(RR) 
0.66, 95% confidence interval (CI) 
0.48-0.90; and RR 0.84, 95% CI 
0.73-0.97, respectively).  
compared to oral 
or no treatment. 
No reduction in 
mortality. Reduced 
blood transfusion 
rates. Despite 
showing a greater 
hemoglobin 
response than oral 
iron, IV iron failed 
to show any other 
benefits over oral. 
Peters (2018) 
Investigate use 
of IV iron in 
the pre-/post-
operative, 
settings 
20 RCTs, 7 
observational 
trials, and 5 
retrospective 
studies   
English articles, 
only studies with a 
control group  
Measured hemoglobin 
levels, reticulocyte 
counts, and/or RBC 
concentrates.  
-Pre- increased hemoglobin levels 
0.4-1.2 g/dL, reduced RBC use  
-The number of trials for IV iron in 
the post-operative setting is low and 
further research is needed.  
IV iron use 
strongest in the 
preoperative 
setting, and an 
individual 
treatment decision 
post-operatively  
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Appendix G 
PARiHS Model 
 
 
 
Adapted from “Enabling the implementation of evidence-based practice: a conceptual 
framework,” by A. Kitson, G. Harvey, and B. McCormack. Copyright 1998 by Quality and 
Safety in Health Care. 
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Appendix H 
Site Advisor Approval Letter 
Available upon request.  
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Appendix I 
Kotter’s Eight Step Change Model 
 
 
 
 
Adapted from “Kotter’s 8-Step Process”, by J. Kotter. Copyright 2017 by Kotter International  
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Appendix J 
Referral Process in Anemia Management for outpatient CABG 
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If Hgb < 13 for men or < 12 for women, first evaluate the CBC and MCV 
(If this is first anemic CBC, encourage healthy diet and recheck in 3 months. If Hgb still low, proceed) 
 
Appendix K 
Outpatient Anemia Algorithm 
 
 
 
 
 
 
BOTH 
Routine 
Outpatient 
Monitoring 
Not  
Corrected 
Fe Deficiency 
Corrected No/Minimal 
Improvement 
Improved/Corrected 
Intolerance 
to PO 
No Yes 
Normal B12/folate 
Folate < 4ng/mL B12 < 400pg/mL 
Microcytic (MCV < 80) 
Check Ferritin, Iron and IBC Level 
 
Normocytic (MCV 80-100) 
Consider anemia of chronic disease, 
renal insufficiency, hemolysis, 
nutritional deficiency. 
 
Macrocytic (MCV > 100) 
Check Folate and Vitamin B12 levels 
(Liver disease, hypothyroidism, metformin, phenytoin, 
malnutrition can cause deficiency) 
Folate 
(Must correct B12 first) 
Daily MVI or suppl. with 
1mg folate.  
 
Can also increase leafy 
greens, nuts, whole grain 
cereals, banana intake 
 
Recheck in 3 months 
 
 
 
Vitamin B12 
Level 150-400pg/mL: B12 
1000mcg PO daily OR 
1000mcg IM monthly 
Level < 150pg/mL: B12 
1000mcg IM qWeek x4, 
then 1000mcg PO daily OR 
1000mcg IM monthly 
 
- Recheck in 3 months 
- Increase egg, meat, fish, 
and dairy intake  
Check 
Iron, B12, 
Folate 
studies 
Consider peripheral 
smear for additional 
workup (hematology 
consult if Hgb < 10g/dL) 
Ferritin < 30 mcg/L Ferritin 31-99 
mcg/L 
Ferritin > 100 
mcg/L 
TIBC > 400mcg/dL  
OR Iron Level < 40mcg/dL 
OR Iron Saturation < 15% 
Iron Deficiency 
See Treatment 
Pathways Below 
No Iron Deficiency 
Consider 
hematology consult  
Iron Replacement 
Algorithm 
Ferritin < 30 mcg/L 
OR surgery/procedure 
planned in next 3 months 
OR new, severe symptoms 
OR Hgb < 9g/dL 
All Others 
Ferrous Sulfate 325mg PO TID 
- Take with water/juice on empty stomach 
- GI upset common! Try taking with food 
before discontinuing 
- If taking antacids/H2RA/PPI: 
    * Take FeSO4 1 hour before acid-blocker 
    * Take FeSO4 with juice 
Recheck 
studies in 
3 months 
Ferrous Sulfate 325mg PO BID 
Lifelong (?) as tolerated 
Intravenous Ferric Carboxymaltose x 2 doses 
< 50kg: 15mg/kg on day 1; repeat dose in 7-10 days 
> 50kg: 750mg on day 1; repeat dose in 7-10 days 
**Other relevant info here re: infusion center?** 
Recheck 
studies in 
1-3 months 
Can repeat course if 
anemia reoccurs 
Check LDH, 
haptoglobin 
Treat 
deficiency 
as shown 
If hemolysis 
present, consult 
hematology 
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Appendix L 
Scripting Tip Sheet for CTS: Referral to PAC 
 
 
  
 
1 
Surgical Optimization Center 
330 Barclay NE, Suite 104/ MC197 
Grand Rapids, MI 49503 
616.267.9823 fax 616.267.8414 
 
Adam Edlund, MD, SFHM  
Medical Director, Perioperative Medicine 
adam.edlund@spectrumhealth.org 
Preoperative Assessment Center (PAC) 
Scripting for Cardiothoracic Patients 
 
 
 
Epic Referral Code: REF943 – Choose Butterworth location 
 
Information for your patients why they are being referred to the SOC: 
 
 
1. Why am I being referred to the PAC for medical evaluation and not my PCP? 
 
Your surgeon has identified that your diagnosis of________ may put you at higher risk of post-operative complications. We 
would like to optimize your ___(diagnosis)____prior to surgery to lower your risk for complications. Our goal is to make your 
surgery as safe as possible. The PAC provides assessments of medically complex patients. The PAC providers work directly 
with anesthesiology and your surgeon to ensure your safety for surgery. A thorough evaluation of your medical, surgical, family 
history, and medications you are currently taking will better inform your surgeon of your risk of surgery. The PAC team will also 
give you instructions on which medications you can take prior to your surgery. They will also order any appropriate testing or 
lab work that may be needed. The PAC can also help arrange home health services, if needed, when you are home. All of this 
information will be communicated to your surgeon and your PCP. 
 
2. Will this delay my surgery?  
 
The PAC is efficient in evaluating your needs based on the type of surgery, anesthesia, and your medical history. It is 
important that you are “optimized” or at your least risk possible of having complications during and after surgery. Other testing 
may be ordered to ensure your safety. This may at times cause some delay. This will be communicated to your surgeon.  
 
3. What happens next? 
 
A referral will be placed to the PAC by your surgeon. The PAC team will call you within 1-2 days to schedule your evaluation 
with one of their providers, usually 2 weeks prior to surgery.   
 
4. What do I need to bring to my appointment at the SOC? 
 
• A complete list of your medications and any over-the-counter medications, vitamins, and other supplements, including 
how often you take them 
• Information about your medical conditions and prior surgeries 
• You do not have to fast for this appointment 
• The appointment will take approximately 45 minutes to 1 hour 
 
5. Additional Information 
• When the PAC calls the patient to schedule their appointment we will go over all this information with them and send 
them directions. 
• Any additional notes put into the EPIC referral from the cardiothoracic team is helpful 
• PAC team will communicate any patient concerns back to the cardiothoracic surgeon  
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Appendix M 
Post-Implementation CTS Provider Satisfaction Survey Tool 
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in 
outpatient CABG patients 
1. This process change had no impact on my workflow. 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
2. The referral process between the PAC and CTS was easy to navigate. 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
3. The appointment at the PAC was convenient for my patients.  
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
4. The preoperative optimization of my patients at the PAC met my expectations.  
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
5. The communication between the PAC and CTS has met my expectations.  
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
6. I am likely to continue to refer my patients to the Preoperative Assessment Center for 
preoperative management in the future. 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
Any comments or ideas for improving the process: ____________________________________ 
______________________________________________________________________________
______________________________________________________________________________  
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Appendix N 
Post-Implementation PAC Provider Satisfaction Survey Tool 
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in 
outpatient CABG patients 
1. This process change had no impact on my workflow. 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
2. The referral process between the PAC and CTS was easy to navigate. 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
3. Ordering iron infusions through Epic was an easy process to navigate.  
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
4. The communication between the PAC and CTS has met my expectations.  
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
5. I recognize the benefit of this referral process and am likely to continue to support it.  
Strongly Disagree  1 2 3 4 5 Strongly Agree 
 
 
 
Any comments or ideas for improving the process: ____________________________________ 
______________________________________________________________________________
______________________________________________________________________________ 
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Appendix O 
Table of Measures 
 Concept 
measured 
How 
measured 
(tool, survey, 
variable) 
When measured Who measures 
Clinical 
System 
Change 
Referral to PAC to 
anemia workup 
and treatment 
Presence of 
referral order 
yes/no, 
presence of 
treatment 
yes/no: one 
sample test of 
proportions 
December 2018-
March 2019, 
throughout 
implementation 
DNP Student 
Clinical 
System 
Change 
Blood utilization  Chart audits, 
Blood 
Utilization 
Dashboard: 
Wilcox Rank 
Sum Test 
December 2018-
March 2019, 
throughout 
implementation 
DNP Student 
Patient 
Outcomes 
Hemoglobin 
change  
Chart audits: 
Wilcox Rank 
Sum Test 
December 2018-
March 2019, 
throughout 
implementation 
DNP Student 
Sustainability Provider/clinician 
satisfaction for the 
process change  
Survey: Likert 
scale 
Post-
Implementation  
DNP 
Student/CTS/PAC 
Practice Manager 
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Appendix P 
CABG Patients Chart Audit Tool – Surgical Referral 
Age: ______    
Reviewer Name: __________________________ 
 
Questions   Chart Review Data 
Does the patient have 
a recent Complete 
Blood Count done 
PRIOR to a cardiac 
catheterization? 
 
Yes 
 
No 
 
N/A 
Is the patient anemic 
according to WHO 
standards? 
(Hemoglobin < 13 in 
men; < 12 in women) 
 
Yes 
 
No 
 
Hgb level prior to cardiac catheterization: ___ 
If anemic, were follow 
up labs ordered based 
on the MCV (iron 
studies, vitamin B12, 
folate, etc.) 
 
Yes 
 
No 
 
MCV: _____ 
If yes, what labs were ordered?: _______________ 
_________________________________________ 
Was referral to the 
PAC made? 
Yes No N/A 
Was the patient’s 
anemia 
addressed/treated? 
Yes No If Yes, what treatment?: _____________________ 
Surgery: N/A N/A Full name of surgery: _______________________ 
Date/Hgb prior to surgery: ___________________ 
Was blood used 
during surgery? 
Yes No If yes, type and quantity of blood used: _________ 
_________________________________________ 
Was blood used after 
surgery?  
Yes No Hgb after surgery: 
If yes, type and quantity of blood used: _________ 
_________________________________________ 
 
Additional information: __________________________________________________________ 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
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Appendix Q 
Project Budget 
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Appendix R 
Project Timeline 
 
 
1
•Complete proposal and acceptance of project by faculty at GVSU and key stakeholders within the 
organization by end of November 2018
2
•Present the proposed referral process to CTS and to the PAC by December 2018 for feedback and 
comments.
3
•Collect current data on anemia in CABG patients using retrospective chart audits on the current state 
of anemia management by November 30, 2018.
4
•Present and educate CTS and PAC on final referral process and information on the anemia managment 
order set by December 2018.
5
•Additional lab work will be drawn if indicated to determine type of anemia. Anemic patients will be 
referred to the PAC for management of anemia prior to CABG surgery after initial surgical consultation 
for the implementation period of December 2018 through February 2019. 
6
•Send weekly progress reports on the progress of the new process to key stakeholders during project 
implementation, December 2018 through February 2019.
7
•Collect post-implementation data under the new process (December 2018-February 2019) and the 
deliver final report to appropriate healthcare providers by March 2019.
8
•Deliver final reports to site mentor, practice managers, medical directors, and key stakeholders by 
March 2019.
9
•Give a post-implementation survey regarding provider satisfaction to help clarify added value and 
process sustainability in March 2019.
10
•Present results during April 2019 staff meeting, and give credit to all staff members who were involved 
with the project
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Appendix S 
Results: Anemic Outpatient CABG Patients Treated 
 
  
0% 10% 20% 30% 40% 50% 60% 70%
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Appendix T 
Results: Blood Usage for Intervention and Usual Care Groups 
 
 
 
 
  
0
7
2 2
1 1
0 0 0 0 0 0
1
00
1
0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0
0
1
2
3
4
5
6
7
8
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14
Un
its
 o
f B
lo
od
 U
se
d
Patients
Intervention group Blood Usage
PRBCs Platets FFP Cryo
0 0 0 0
2
0 0
2
0 00 0 0
1
2
0 0 0 0 00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0
1
0
0
1
2
3
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
Un
its
 o
f B
lo
od
 U
se
d
Patients
Group 2 Blood Usage
PRBCs Platets FFP Cryo
PREOPERATIVE ANEMIA MANAGEMENT  
 
 
75 
Appendix U 
Results: Post-Implementation Provider Survey Results 
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Appendix V 
PowerPoint Doctoral Defense Presentation 
 
 
 
 
 
Katherine Mills
DNP Project Defense
April 15, 2019
Preoperative Anemia 
Management in Adult 
Outpatient Coronary 
Artery Bypass Graft 
Surgical Patients to 
Improve Treatment of 
Preoperative Anemia
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Objectives for Presentation
1. Review the clinical problem: preoperative anemia 
within the context of the organizational assessment
2. Review the literature review and proposed solution
3. Review the project plan, including theoretical 
models
4. Present results and sustainability plan
5. Discuss implications for practice, DNP essentials, 
and dissemination plan
Introduction
• Anemia: Hemoglobin concentration of less than 12 g/dL in 
non-pregnant women and less than 13 g/dL in men. 
• Almost 50% of anemia is due to iron deficiency (World Health 
Organization, 2008)
• Anemia and red blood cell transfusions (aRBCt) are 
independently associated with poor outcomes after cardiac and 
non-cardiac surgery (Clevenger et al., 2016; ; dos Santos et al., 2013; 
Hung, Besser, Sharples, Nair, & Klein, 2011; Shander et al., 2010)
• Preoperative anemia is common among cardiac surgical 
patients à more likely to need blood transfusion in the 
perioperative period. 
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Project Purpose
• To implement an evidence-based practice 
improvement initiative to improve the 
treatment of iron deficiency anemia prior to 
coronary artery bypass (CABG) surgery in a 
large Midwestern health system (MHS) by 
restructuring the preoperative optimization 
process. 
• Cardiothoracic Surgery (CTS) – Preoperative 
Assessment Center (PAC) collaboration
Organizational 
Assessment
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IRB Approval
• Site Institutional Review Board (IRB)
• Scope limited to quality improvement 
• GVSU Human Research Review Committee 
• Project not defined as research
Assessment of Organization
• Organizational assessment completed between May-
August 2018
• Burke and Litwin Model (1992)
• Assessment included:
– External factors (blood scarcity)
– PAC & CTS: # providers and staff, # patients, and 
bandwidth, readiness for change
– Cardiovascular Medicine: process of referral to CTS
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Assessment of Organization
The Burke and Litwin Model of Organizational 
Performance and Change (1992) (Burke & Litwin, 1992)
SWOT - PAC
Strengths
• Aesthetically pleasing building
• Part of a Magnet designated hospital system
• Motivated leaders and staff that support change 
projects.
• Consistent providers that specialize in 
preoperative assessment
• Close relationship to the hospital where surgeries 
take place
• Cohesive pre-surgical optimization visit
Weaknesses
• Gaps in needed staff; need pharmacy, dietician, and 
more advanced practice providers
• Lack of infusion chairs readily available
• Need additional staff to provide more in depth 
education classes. 
Opportunities
• Blood shortage, need for management to decrease 
the use of blood products
• Has bandwidth to see more patients
• Close relationship with hospitalists and referring 
providers and anesthesia, leads to effective 
communication streams
• Enhanced quality of care by incorporating evidence-
based practice
• A positive relationship between the PAC and 
other surgery practices in the organization 
Threats
• Individual barriers to change, unwillingness to 
change
• Ordering infusions is a confusing process at this 
organization
• No current relationship with cardiothoracic surgery.
• Patients unable to get to infusion clinic/pay for new 
iron infusion supplements. 
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Key Stakeholders
• CTS personnel (surgeons, schedulers, RNs, 
clinical practice managers)
• PAC personnel (medical director, nurse 
practitioners, practice manager, medical 
assistants, educators)
• Site pharmacists, infusion clinic staff, 
cardiovascular medicine staff, quality 
improvement specialists
Current State – Outpatient Referral
• Patient is identified as having multivessel disease 
following diagnostic heart catheterization 
• Referral to CTS is made
• CT Surgeon meets with patient 
• Surgery is scheduled within 2-3 weeks. 
• The patient is referred to their primary care provider 
for preoperative assessment
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Society of Thoracic Surgery (STS) 
Adult Cardiac Surgery Registry
• 38% of all patients at MHS who undergo cardiac 
surgery are anemic at the time of surgery. 
• Further, approximately 30% of MHS patients 
from the outpatient setting who undergo CABG 
surgery are anemic 
• Of this 30%, only 17% of anemic, outpatient 
CABG patients were identified as anemic prior to 
surgery and were given treatment at MHS.
Clinical Practice Question
• If patients are referred to a preoperative 
assessment center prior to CABG surgery for 
preoperative anemia work-up, will the number 
of patients undergoing CABG surgery with 
untreated anemia decrease?
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Literature Review
Literature Review Aims
• Typical treatment for iron deficiency: iron 
supplementation and erythropoietin (EPO)
• To determine best practice for preoperative anemia 
management: 
– Does any formulation of iron supplementation therapy 
increase hemoglobin concentration in anemic patients?
– What formulation of iron supplementation is safe and 
effective in improving hemoglobin levels in anemic 
patients? 
– What formulation of iron supplementations reduces the risk 
of aRBCt in anemic patients?
– Is EPO therapy safe and efficacious in reducing the use of 
aRBCt in cardiac surgery?
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Review Method
• PRISMA guidelines served as the framework 
for the review. (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009)
• Keywords included: anemia, preoperative anemia, 
cardiac surgery, anemia management, cardiac, adult, 
iron infusion, erythropoietin, systematic review, 
meta-analysis, and randomized control trial. 
PRISMA
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Literature Review
• Included: 
– Two Cochrane Reviews (Clevenger et al., 2016; Gurusamy et al., 2014)
– Two systematic reviews (Lin et al., 2013; Litton et al., 2013)
– Three randomized control trials (RCT) (Cladellas et al., 2012; Weltert et al., 2015; Yoo et al., 2011)
– One comprehensive review article (Peters et al., 2018) 
• Conclusion: Iron therapy and/or EPO to correct 
preoperative anemia is both safe and efficacious. 
(Clevenger et al., 2016; Gurusamy, Nagendran, Broadhurst, Anker, & Richards, 
2014; Lin, Lin, & Tran, 2013; Litton, Xiao, & Ho, 2013; Peters et al., 2018) 
Literature Review Results Summary
• The authors of all eight articles described a 
decrease in blood transfusion requirements 
after iron supplementation and/or EPO 
injection (Clevenger et al., 2016; Gurusamy et al., 2014; Lin et al., 2013; Litton et al., 2013; 
Cladellas et al., 2012; Weltert et al., 2015; Yoo et al., 2011; Peters et al., 2018) 
• The authors of five studies measured an 
increase in hemoglobin after the use of 
preoperative IV iron supplementation (Clevenger et al., 
2016; Gurusamy et al., 2014; Lin et al., 2013; Litton et al., 2013; Peters et al., 2018)
• The authors of three studies saw a decrease in 
mortality (Clevenger et al., 2016; Cladellas et al., 2012; Weltert et al., 2015)
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Evidence for Project
• Anemia is associated with worse outcomes and 
increased mortality after cardiac and non-
cardiac surgery (Clevenger et al., 2016)
• Correcting anemia prior to surgery may 
decrease the risk of blood transfusion 
associated adverse events and shorten length 
of hospital stays (Clevenger et al., 2016; Cladellas et al., 2012)
• Correcting preoperative anemia is safer for 
patients and cost effective. (Shander, et. al., 2010)
Phenomenon Conceptual Model -
PARiHS
Adapted from “Enabling the implementation of evidence based practice: a 
conceptual framework,” by A. Kitson, G. Harvey, and B. McCormack. Copyright 
1998 by Quality and Safety in Health Care. (Kitson, Harvey, & McCormack, 1998) 
PREOPERATIVE ANEMIA MANAGEMENT  
 
 
87 
 
 
 
 
Project Plan
Project Objectives
1. Introduce a new referral process to the PAC for 
CABG patients to treat anemia and other 
comorbidities
2. Improve the treatment of anemia in perioperative 
setting among CABG patients
3. Provide evidence that the referral process 
increased treatment of anemia in CABG patients
4. Evaluate provider satisfaction to clarify added 
value and sustainability
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Project Purpose
• Purpose: implement an evidence-based 
practice improvement initiative to improve the 
treatment of iron deficiency anemia prior to 
CABG surgery at MHS by restructuring the 
preoperative optimization process. 
Design
• Quality improvement project
• The implementation process was guided by 
Kotter’s eight steps of change (Kotter, 1996)
– Three phases
• Creating climate for change
• Engaging and enabling the organization
• Implementing and sustaining for change
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Implementation Model - Kotter
Adapted from “Kotter’s 8-Step Process”, by J. Kotter. 
Copyright 2017 by Kotter International (Kotter, 1996)
Setting & Participants
• The PAC offers a standardized approach to 
preoperative medical evaluation and 
management to avoid preventable 
complications and mortality
• Participants:
– Outpatient CABG candidates
– Healthcare providers (RNs, APPs, cardiologists, 
cardiothoracic surgeons, MAs)
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Assess 
Readiness
• Organizational assessment
• SWOT analysis
• Shadowing experiences
Build 
Coalition
• Building positive relationships
• Gathering key stakeholders
• Forming subcommittees
Develop 
Education
• Strategies for provider education
• Presenting initial process draft to key stakeholders
• Educate CTS/PAC on new pilot assessment process                             
for CABG patients
May-July 
2018
May-Nov 
2018
Oct - Dec 
2018
Implementation Strategy & Elements
(Powell, et al., 2015)
Conduct 
Change Tests
• Patients will be referred to PAC after initial surgical                         
consult
• CTS will order the additional laboratory studies needed
• PAC will optimize patient for surgery, will order anemia treatment
Provide 
Feedback
• Weekly progress reports to providers on progress of                          
pilot project
• Post-implementation data will be collected
Share 
Knowledge
• Final project results shared with key stakeholders
• Post-implementation satisfaction survey distributed and                  
collected
Dec 2018-
Mar 2019
Mar 2019
Implementation Strategy & Elements
(Powell, et al., 2015)
Dec 2018-
Feb 2019
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Timeline
1
• Complete proposal and acceptance of project by faculty at GVSU and key stakeholders 
within the organization by end of November 2018
2
• Present the proposed referral process to CTS and to the PAC by December 2018 for 
feedback and comments.
3
• Collect current data on anemia in CABG patients using retrospective chart audits on the 
current state of anemia manamgent by November 30, 2018.
4
• Present and educate CTS and PAC on final referral process and information on the 
anemia management order set by December 2018.
5
• Send weekly progress reports on the progress of the new process to key stakeholders 
during the project implementation for nine weeks during project implementation.
6
• Collect post-implementation data under the new process (December 2018-February 
2019) and the deliver final report to appropriate healthcare providers by March 2019.
7
• Deliver final reports to site mentor, practice managers, medical directors, and key 
stakeholders by March 2019.
8
• Give a post-implementation survey regarding provider satisfaction to help clarify added 
value and process sustainability in March 2019.
9
• Present results during April 2019 staff meeting, and give credit to all staff members who 
were involved with the project
Referral Process to PAC
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Outpatient Anemia Algorithm
Evaluation & Measures
Concept measured How measured
(tool, survey, variable)
When measured Who measures
Referral to PAC to 
anemia workup and 
treatment
Presence of referral order yes/no, 
presence of treatment yes/no
December 2018-March 
2019, throughout 
implementation
DNP Student
Blood Utilization A comparison of a random sample 
of 10 patients (usual care group) 
not involved in the pilot project 
compared to the intervention 
group
December 2018-March 
2019, throughout 
implementation
DNP Student
Post-Operative 
Hemoglobin Change 
Average post-operative 
hemoglobin in the intervention 
group and the average post-
operative hemoglobin in the usual 
care group (n=10)
December 2018-March 
2019, throughout 
implementation
DNP Student
Provider/clinician 
satisfaction for the 
process change 
Survey Post-Implementation DNP 
Student/CTS/PAC 
Practice Manager
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Analysis Plan
• Data will be analyzed with support of university 
graduate student statistician. 
– One sample test of proportions: The proportion of patients 
entering surgery treated for anemia pre- and post-
implementation
– Wilcox Rank Sum Test: 
• A comparison of blood product usage of a random sample of 10 
patients (usual care group) not involved in the pilot project 
compared to the intervention group (n=14)
• Average post-operative hemoglobin in the intervention group 
(n=14) and the average post-operative hemoglobin in the usual 
care group (n=10).
• Sustainability: Post-implementation survey regarding 
provider satisfaction
Results
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Results: Participant Characteristics
– Intervention Group: Patients involved in the pilot 
project that were screened using new referral process 
(n=14)
• Average age: 63.8 years; 21.4% female
– Usual Care Group: Random sample of elective 
CABG patients that were not involved in the pilot 
project (n=10) 
• Average age 68.8 years; 10% female
– One surgeon’s elective CABG patients were screened 
for full 12 weeks of implementation, another surgeon’s 
elective CABG patients screened for last four weeks of 
implementation.
Results: Patients Screened
• 14 patients total screened in Intervention Group
• 42.86% (6 of 14) were anemic at the time of 
surgical consultation
– 83.3% (5 of 6) were properly referred
– 66.6% (4 of 6) were treated, compared to 17% (7 of 
41) of anemic outpatient CABG patients pre-
implementation (p=0.006)
• 49.6% (17% to 66.6%) increase in anemia 
treatment
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Results: 
Blood 
Product 
Usage
(p=1)
14 aRBCt used in total
6 aRBCt used in total
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Results: Post-Operative Hemoglobin
• There is a clinically significant difference in the post-
operative hemoglobin. This slight rise in hemoglobin, 
despite the high number of anemic patients, is reason 
enough to continue the process. 
Total Average Post-Operative Hemoglobin
Intervention Group
(42.9% (6 of 14) anemic patients)
Usual Care Group
(20% (2 of 10) anemic patients)
10.3 g/dL 10.1 g/dL
p=0.62
Post-Implementation CTS Survey
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in outpatient CABG patients
1. This process change had no impact on my workflow.
Strongly Disagree 1 2 3 4 5 Strongly Agree
2. The referral process between the PAC and CTS was easy to navigate.
Strongly Disagree 1 2 3 4 5 Strongly Agree
3. The appointment at the PAC was convenient for my patients. 
Strongly Disagree 1 2 3 4 5 Strongly Agree
4. The preoperative optimization of my patients at the PAC met my expectations. 
Strongly Disagree 1 2 3 4 5 Strongly Agree
5. The communication between the PAC and CTS has met my expectations. 
Strongly Disagree 1 2 3 4 5 Strongly Agree
6. I am likely to continue to refer my patients to the Preoperative Assessment Center for preoperative management in 
the future.
Strongly Disagree 1 2 3 4 5 Strongly Agree
Any comments or ideas for improving the process: 
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Post-Implementation CTS Survey Results
Q1 Q2 Q3 Q4 Q5 Q6
Surgeon 1 3 5 4 4 2 4
Surgeon 2 3 2 3 3 3 4
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CTS Provider Post Implementation Survey
Likert Scale: 1=Strongly Disagree; 5=Strongly Agree
Q1-Workflow Impact Q2-Referral Process Q3-Conveniency
Q4-Expectation Q5-Communication Q6-Continuation
Post-Implementation PAC Survey
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in outpatient CABG patients
1. This process change had no impact on my workflow.
Strongly Disagree 1 2 3 4 5 Strongly Agree
2. The referral process between the PAC and CTS was easy to navigate.
Strongly Disagree 1 2 3 4 5 Strongly Agree
3. Ordering iron infusions through Epic was an easy process to navigate. 
Strongly Disagree 1 2 3 4 5 Strongly Agree
4. The communication between the PAC and CTS has met my expectations. 
Strongly Disagree 1 2 3 4 5 Strongly Agree
5. I recognize the benefit of this referral process and am likely to continue to support it. 
Strongly Disagree 1 2 3 4 5 Strongly Agree
Any comments or ideas for improving the process: 
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Post-Implementation PAC Survey Results
Q1 Q2 Q3 Q4 Q5
Provider 1 3 5 4 4 4
Provider 2 2 3 3 3 4
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PAC Provider Post Implementation Survey 
Likert Scale: 1=Strongly Disagree; 5=Strongly Agree
Q1-Workflow Impact Q2-Referral Process Q3-Ording Infusions
Q4-Communication Q5-Continuation
Discussion
• 49.6% increase in anemia treatment 
• aRBCt usage: no statistical change
– One patient outlier in Intervention Group, used 7 aRBCt 
alone
• Post-op hemoglobin improvement: clinical 
significance 
– 50% (2 of 4) were treated with IV iron: increase in IV 
iron use for more robust hemoglobin recovery post-op (Lin 
et al., 2013)
• Provider Satisfaction: all providers surveyed willing 
to continue the new referral process
• In addition to anemia treatment, patients also 
received assessment of chronic disease from PAC
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Limitations
• Short implementation period
• Small sample size
– Unable to generalize findings
– Difficult to evaluate statistical significance
• Referred two surgeon’s CABG patients only, 
smaller than originally anticipated
• CTS scheduler on leave, less than expected buy-in 
from new staff
• In future: 
– Evaluate perioperative blood loss
– Survey nursing staff members, not just providers
Resources 
& Budget
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Implications for Practice
• Referral to the PAC resulted in successful 
treatment of iron deficiency anemia for 
preoperative CABG patients
• Referral to the PAC will expedite management 
of anemia as well as other chronic conditions 
impacting surgical outcomes
Sustainability Plan
• This referral process on anemia management 
in CABG patients will remain in place after the 
completion of this project.
– Potential for expanding into different CTS 
procedures.
– Large buy-in from leaders
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Dissemination 
• Shared results with leadership and participants 
of CTS and PAC on April 10, 2019
• Project presented at open forum poster 
showcase at the organization in April 2019
• Final draft to be published in ScholarWorks© 
Conclusions
• A Midwest health organization sought to increase 
anemia treatment prior to CABG surgery
• Organizational assessment and literature review 
were conducted
• New referral process for CABG patients was 
implemented with a CTS and PAC collaboration 
• Treatment of anemia increased by 49.6% for 
patients following the treatment pathway
• Project workflow and treatment algorithm have 
been adopted as standard work for anemic 
patients requiring cardiothoracic surgery
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DNP Essentials Reflection
I. Scientific Underpinnings for Practice
– Evidence-based treatment through literature review: Oral 
iron IV iron, Epogen
– Use of PARiHS and Kotter’s 8-Step Change Model
II. Organizational and Systems Leadership
– Performing organizational needs assessment
– Cost analysis performed
– Obtained IRB approval from MHS and GVSU
III. Clinical Scholarship and Analytical Methods
– Research based interventions.
– Dissemination of results
DNP Essentials Reflection
IV. Information Systems/Technology
– Use of a quality dashboard for blood utilization
– Regular chart audits
V. Advocacy in Health Care Policy
– Change in standard practice at CTS and PAC
VI. Interprofessional Collaboration
– Collaborated with numerous disciplines (pharmacy, 
surgeons, APPs, RNs, clinical program specialists, 
quality improvement specialists)
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DNP Essentials Reflection
VII. Clinical Prevention Population Health 
– Focused on CABG patient population – specific 
needs relating to anemia.
VIII. Advanced Nursing Practice
– Developed partnerships with providers 
– Facilitator for project
– Implementation of evidence-based intervention
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